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respectively. Snapin selectively increased the current density of 
CaV2.1[EFb] and CaV2.2[EFa], but not CaV2.1[EFa] and CaV2.2[EFb]. 
Moreover, snapin preferentially modulated CaV1.3 channel by 
interacting with the I-II loop region but not on the other calcium channel 
of CaV1 families. In addition, voltage-gated calcium channels were 
modulated by anti-ganglioside antibodies. The antibodies against 
ganglioside are found in patient sera of Guillain-Barré syndrome, 
though the underlying pathogenesis is not clear yet. We discovered 
that anti-ganglioside antibodies modulated voltage sensing of the Ca2+ 
channel. The opening threshold of voltage-gated calcium channel are 
either reduced or increased by anti-GM1 and anti-GQ1b antibodies 
respectively. These interactions between voltage-gated calcium 
channel and anti-ganglioside antibodies are dependent on the auxiliary 
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1.1 Voltage-gated calcium channel 
1.1.1 The classification of voltage-gated calcium channel 
Voltage-gated calcium channels (VGCC) are a group of pivotal ion 
channels involved in several cellular functions.  VGCCs transduce the 
electrical input of voltage depolarization into biochemical output of Ca2+ 
ion influx into the cell. These Ca2+ ions act as universal messengers to 
initiate diverse physiological activities such as synaptic transmission, 
hormone release, muscle contraction, enzymatic activation, gene 
expression or cellular differentiation (Catterall 2000, Catterall & Few 
2008, Evans & Zamponi 2006). The variety of downstream events 
subsequent to Ca2+ influx is achieved by the precise modulations of 
specific VGCC functions. The voltage-gated calcium channel (CaV) is 
composed of several subunits, forming a hetero-oligometric complex 
(Takahashi et al 1987). The α1 subunit is the major pore-forming 
subunit encoded by 10 distinct genes, which determine the 10 
subtypes of CaV channels (Tsien et al 1988). Based on genetic 
homology and pharmacology, these 10 VGCCs could be categorized 
into three major sub-families, as shown in table 1, and they include 
CaV1 (CaV1.1, CaV1.2, CaV1.3 and CaV1.4; all are L-type channels), 
CaV2  (CaV2.1, P/Q type; CaV2.2, N-type and CaV2.3 R-type) and CaV3 
(CaV3.1, CaV3.2, CaV3.3, all are T-type channels) (Ertel et al 2000, 




1.1.2 The subunits of voltage-gated calcium channel 
The α1-subunit is composed of four major domains, called domains I-IV. 
Each domain contains six trans-membrane segments (S1-S6) and a P-
loop region between S5 and S6 forms the selectivity filter that is 
important for gating ion influx (Heinemann et al 1992, Yu et al 2005). 
The S4 helix is considered as an important component of the voltage 
senor and on it is found several positive charged residues including 
arginine (R) and lysine (K). The translocation of S4 in response to 
membrane depolarization is the critical process in opening the voltage-
gated calcium channel (Bichet et al 2003, Yi & Jan 2000). The VGCC 
also contains an intracellular N- and C-terminus and several 
cytoplasmic loops connecting the domains. These intracellular loops 
could interact with and be modulated by various proteins including the 
β subunit, synaptic proteins, calmodulin, G-proteins and various 
kinases or phosphatases (Catterall 2000). 
Table 1.1 Nomenclature and distribution of voltage-gated calcium channels. 




 CaV1.2 Heart, nervous system, smooth 
muscle, endocrine system 
 CaV1.3 Nervous system, cochlear, endocrine 
system, sino-atrial node 
 CaV1.4  Retina 
CaV2 CaV2.1 P/Q type Nervous system 
 CaV2.2 N-type Nervous system 
 CaV2.3 R-type Nervous system 
CaV3 CaV3.1 
T-type 
Nervous system, heart 
 CaV3.2 Nervous system, heart 





Figure 1.1 Schematic diagrams of the trans-membrane topology and subunit 
compositions of CaV channel. 
The α1 subunit of CaV is composed of four major domains (I-IV). Each domain 
contains six trans-membrane segments (S1-S6). The S4 segment forms the voltage 
sensor and the loop region between S5 and S6 is responsible for ions gating. The 
cytoplasmic linkers between the domains are involved in many protein interactions. 
For example, the I-II loop interacts with CaVβ. II-III loop is synaptic protein interaction 
site (synprint). Pre-IQ, IQ domain and N-terminus of CaV1 and CaV2 are associated 
with calmodulin (CaM) binding. Exon 37 of CaV1 and CaV2 is under alternative 
splicing and forms EF-hand like domain. 
CaVα2δ subunit is attached to the extracellular membrane and linked with plasma 
membrane via GPI anchor. The CaVβ binds with the I-II loop of the VGCC. CaM 
interacts both the N and C-terminus of VGCC in varied local Ca2+ concentration. The 
CaVγ subunit has been omitted.  
Both the CaV1 and CaV2 sub-families contain auxiliary β- and α2δ-
subunits and/or the γ-subunit (Takahashi et al 1987). Four genes have 
been found to encode CaVβ subunits (β1-β4) and alternative splicing of 
these genes generate several CaVβ variants (Buraei & Yang 2010). 
The CaVβ subunit binds to the I-II loop region of the α1-subunit and 
enhances the surface expression of the VGCC (Pragnell et al 1994); 
(Van Petegem et al 2004). Recent studies from the Zamponi’s group 
have shown that CaVβ influences the ubiquitination of CaV1.2 channels 
and therefore regulates the channel’s surface expression (Altier et al 
2011). CaVβ has been shown to play a role to traffic the CaV channel 




loop. The absence of the β-subunit would result in the ubiquitination of 
CaV α1-subunit. Mutations on the β-subunit binding domain (or other 
proteins competing for the binding of the β-subunit would lead to 
ubiquitination of the calcium channel and subsequent degradation the 
channel complex. 
The α2δ-subunit is encoded by four genes (α2δ1-α2δ4) (Dolphin 2013). 
The α2δ subunit is transcribed by one gene and cleaved into two parts, 
which is subsequently linked by disulfide bond (Davies et al 2007). The 
α2δ-subunit is also involved in trafficking of the calcium channel. Co-
expression of α2δ-subunits augments the calcium channel current in 
the cell membrane (Arikkath & Campbell 2003). The α2δ-subunit also 
plays a crucial role in synaptic vesicle release by recruiting VGCC to 
the pre-synapse active zone (Hoppa et al 2012). Recent studies have 
suggested that the α2δ-subunit is anchored to the plasma membrane 
by glycerophosphatidylinositol (Davies et al 2010, Kadurin et al 2012). 
The γ-subunit is only co-expressed with CaV1.1, the skeletal muscle L-
type channel (Arikkath et al 2003, Campbell et al 1988). It is not clear 
whether the neuronal type of VGCC also includes the γ-subunit, though 
the expression of several isoforms of γ-subunit has been found in 
neuron (Letts et al 1998, Rousset et al 2001).  
Several studies have shown that calmodulin (CaM) is associated with 
VGCC and modulates activity-dependent channel properties, and 
recently it has been suggested that CaM should be considered as the 




Findeisen 2010, Peterson et al 1999, Zuhlke et al 1999). The auxiliary 
subunits are required for the proper function of CaV1 and CaV2 families, 
while CaV3 families are reconstituted well in the heterologous 
expression systems with the CaV α1 subunit alone (Perez-Reyes 2003).  
1.2 Physiological and pathological properties of 
voltage-gated calcium channel 
1.2.1 CaV2.1 and CaV2.2 channels 
The CaV2.1 channel is highly represented in the central and peripheral 
nervous systems and mediates presynaptic and somatodendritic Ca2+ 
influx (Mori et al 1991, Starr et al 1991). Ca2+ influx via the CaV2.1 
channels trigger several Ca2+-related responses. Although CaV2.1 
function could be partially compensated by CaV2.2, dysfunction of 
CaV2.1 has severe consequences. Human CACNA1A mutations have 
been associated with several neurological diseases, including familial 
hemiplegic migraine type 1 (FHM1), spinocerebellar ataxia type 6 
(SCA6) and episodic ataxia type 2 (EA2) (Pietrobon 2010). The CaV2.1 
deficient mice have been reported to suffer from ataxia and motor 
dysfunction (Jun et al 1999). Over the past ten years, 17 mutations of 
the CACNA1A gene associated with FHM1 have been detected. 
CaV2.1 channels with FHM1 related mutations have been shown to 
exhibit relatively larger currents. The excess Ca2+ influx is considered 
as an underlying mechanism for increased susceptibility of cortical 
spreading depression (Cao & Tsien 2005, Hans et al 1999, Tottene et 




result mostly in the loss-of-function of the channels. The 
neurodegenerative disease SCA6 is one of the major CaV2.1 related 
diseases (Ophoff et al 1996, Zhuchenko et al 1997). It is characterized 
by late-onset, slow progressive cerebella ataxia and Purkinje cell 
degeneration in the cerebellum. In patients suffering from SCA6, the 
expansion of polyglutamine (CAG)n was found in the CACNA1A gene. 
The pathology of SCA6 is closely related with the alternative splicing of 
CaV2.1. The CAG repeats are found within the C-terminal alternative 
exon 47. As such, in human there are two variations of CaV2.1 
channels - with or without exon 47. The expanded (CAG)n repeats will 
only become toxic when exon 47 is present in the CaV2.1 channels. As 
the expression of exon 47 is higher in Purkinje than granule cells, it is 
proposed that degeneration of cerebellar Purkinje neurons, but not of 
granule cells, in SCA6 patient results from differential alternative 
splicing of exon 47 in these neurons.  
Similar to CaV2.1, CaV2.2 channels are exclusively expressed in the 
nervous system and Ca2+ influx through these channels also triggers 
synaptic vesicle release in the presynaptic terminals (Nowycky et al 
1985, Westenbroek et al 1992, Wheeler et al 1994). The CaV2.2 
knockout mice have mild central nervous system phenotypes due to 
compensation by CaV2.1 channels. However, these mice are 
hyposensitive to pain suggesting the prominent role CaV2.2 channels 
play in pain transmission (Hatakeyama et al 2001, Kim et al 2001). The 




coupled receptors (Bourinet et al 2014, Bourinet et al 1996, Ikeda 
1996, Tedford & Zamponi 2006). 
1.2.2 Functions and properties of CaV1.3 
The CaV1.3 channel is differentiated from other L-type of calcium 
channels by its low-voltage activation threshold. It plays a prominent 
role in neuronal pace-making in neurons of the suprachiasmatic 
nucleus (Pennartz et al 2002) and in vesicle release at the ribbon 
synapse of inner hair cells (IHC) found in the cochlea (Platzer et al 
2000).  
Deletion of CaV1.3 gene in the mouse genome resulted in congenital 
deafness due to the loss of the Ca2+ influx into the cochlear inner hair 
cells. Loss of function of CaV1.3 due to point mutations have been 
reported to cause congenital deafness and bradycardia in two families 
found in Pakistan (Baig et al 2011). More than 90% of the Ca2+ current 
in cochlear IHCs is carried by the CaV1.3 channels (Platzer et al 2000). 
These channels are clustered at the ribbon synapse of the inner hair 
cell and are tethered for synaptic release (Brandt et al 2005). The IHCs 
are not usually activated by discrete action potentials but by hypo-
threshold graded membrane depolarization. Due to its low threshold of 
activation, the CaV1.3 mediated Ca2+ influx is sensitive to membrane 
potential change and this ensures the precise response to sound 
signaling (Goutman 2012) (Striessnig & Koschak 2008). 
The CaV1.3 channels are robustly inactivated by a rise in Ca2+ influx. 




calmodulin to the IQ motif found at the proximal C-terminus of the 
CaV1.3 channel. Besides alternative splicing that could remove the 
expression of the IQ-domain, RNA editing of CaV1.3 could modify the 
IQ-domain in a pin-point manner by substituting adenosine to 
guanosine at the IQ motif. The edited form of CaV1.3 showed slower 
Ca2+-dependent inactivation and reduced pace-making spike frequency 
in the suprachiasmatic nucleus neurons (Huang et al 2012).  
1.3 Alternative splicing of voltage-gated calcium 
channel 
1.3.1 Mechanism of alternative splicing 
It has been reported that over 70% of genes in the brain are 
alternatively spliced (Gray et al 2007). Alternative splicing is a process 
whereby alternative exons of the pre-mRNA combine in multiple arrays 
to diversify the proteome. That means one gene produces several 
protein isoforms, which result in the generation of functional diversity. 
The common mechanisms for alternative splicing are as follows: (1) 
One alternative cassette exon could be either included or excluded in 
the mature mRNA; (2) Two exons of identical size are mutually 
exclusively included in the transcript; (3) Alternative 5’ or 3’ of exon 
could be spliced leading to a relatively longer or shorter exon; (4) 
Alternative 5’ or 3’ UTR is included in region that could potentially affect 




transcript.  Single pre-mRNA could therefore exhibit multiple splicing 
patterns (Black 2003, Chen & Manley 2009). 
 
Figure 1.2 Common patterns of alternative splicing.  
The constitute exons presence in all mature RNAs were shown in orange box. The 
alternative RNA segments were shown in green and brown boxes. Multiple splice 
patterns could happen in one transcript. A. Exon can be either included or exclude in 
mRNA. B. Two or more adjacent exons were spliced and only one exon was included 
in mature RNA. C, D. Alternative 5’ donor or 3’ acceptor splice sites allow the 
lengthening or shortening of a certain exon. E, F. The transcripts may include an 
alternative 5’ promoter or 3’ poly (A) site, yielding varied products. G. An intron could 





1.3.2 The impact of alternative splicing on voltage-gated calcium 
channels 
Voltage-gated calcium channel is subjected to extensively alternative 
splicing. The splicing pattern of VGCC has varied impact on the 
channel physiology and pathology functions (Gray et al 2007, Liao et al 
2009).  
The C-terminus of CaV1.3 represents an example of extensive splice 
sites that have been characterized. The alternative usage of exon 41 
acceptor site generates a premature stop codon which skip the IQ motif 
of CaV1.3. The truncated CaV1.3 without IQ domain still conducts the 
calcium current, but the calcium dependent inactivation is totally 
abolished (Shen et al 2006). The splicing variant CaV1.3∆IQ is 
selectively localized in outer hear cell. The weak CDI of CaV1.3 found 
in cochlear support the consistent calcium influx, which is crucial for 
early development and synaptic transmission (Brandt et al 2005, Yang 
et al 2006).  
In addition, the downstream exon 42 is spliced by exon 42 or 42a, 
which will generate either long form of CaV1.3 or short form of CaV1.3 
(Xu & Lipscombe 2001). It is shown that the stop codon found in exon 
42a would lead to early truncation immediately after the IQ domain in 
exon 41, while the CaV1.3 transcripts carried the exon 42 contains a 
longer C-terminal. Both long form and short form of CaV1.3 is 
ubiquitously found in the nervous system, but the long form and short 




CaV1.3 display lower current density and reduced CDI compared to the 
short-form. The diminished CDI was attributed to CDI-inhibiting region 
found in the distal C-terminal, which compete the calmodulin binding to 
IQ domain. This CDI-inhibiting region is only found in long form but not 
the short form of CaV1.3 (Liu et al 2010).  
Further studies have reported that the alternative splicing variants of 
CaV1.3 C-terminals have distinct sensitivity to L-type channel blocker, 
dihydropyridine. It is shown that full-length CaV1.342 and CaV1.3∆41 
channels were associated with higher dihydropyridine sensitivity 
compared to CaV1.342a (Huang et al 2013).  
Alternative splicing of CaV2.1 has been characterized in rat and human 
brain or spinal cord (Bourinet et al 1999, Krovetz et al 2000, Soong et 
al 2002). Studies have reported that several alternative splice sites of 
CaV2.1 altered the channel properties. For example, N1605-P1606 
insertion decreases the sensitivity of CaV2.1 to specific blocker ω-Aga 
IVA and the presence of Val421 close to I-II loop of CaV2.1 significantly 
slowed down the channel inactivation kinetics (Bourinet et al 1999). 
These splice variants and selective β subunit composition explain the 
distinct electrophysiological properties between Purkinje cells type (P 
type) and granule cell type (Q-type) of calcium channel, which are both 
encoded by CACNA1A.  
The neurodegenerative disease spinocerebellar ataxia type 6 (SCA6) 
was one the major related channelopathies (Pietrobon 2010, 




progressive cerebella ataxia and Purkinje cell degeneration in the 
cerebellum. In the patient suffered from the SCA6, the expansion of 
polyglutamine (CAG)n was found. The (CAG)n is 6 times more than the 
ordinary human which is 8~10.  
The pathology of SCA6 is closely related with the alternative splicing of 
Cav2.1. The CAG repeats usually attached on the end of exon 47, 
while there is two version of calcium channel with or with out the exon 
47, depending on the splicing site before the exon 47. Such toxic 
(CAG)n repeats will only occur when the exon 47 is present in the 
CaV2.1. Since the expression of exon 47 is higher in Purkinje cell than 
granule cell, it is proposed that more CAG repeats are found in 
Purkinje neuron than granule cell which lead to more severe 
degeneration of Purkinje neuron than that of granule cell in the 
cerebellum. 
Even though, Tsunemi et al (2008) proposed that the extended version 
of Cav2.1 with exon 47 and polyglutamine repeat is increased in 
Purkinje cell of patients, suggested that the splicing factors could be 
affected by the pathology of diseases. These results might result in 
SCA-6 associate selective neural degeneration.  
The pathological mechanism of CaV2.1 has been also studied in 
heterologous expression systems and knock-in mice. The result has 
shown that the splicing pattern also affects the biophysical properties of 
the channel. It has been shown that the biophysical properties of 




context. Toru et al (2000) has indicated an opposite effect on two 
calcium channel splicing variant (+NP and -NP) with expanded 
polyglutamine repeat in CaV2.1. It is shown that the voltage 
dependence of inactivation is reduced (-NP) and enhanced (+NP) 
through polyglutamine-expanded channel depending on the splicing 
variant. Strikingly, Saegusa et al (2006) did not show the similar result 
when they expressed the same -NP human Cav2.1 isoform under the 
native cacna1a promoter in knock-in mice (Saegusa et al 2007). There 
is no difference in the kinetics of voltage activation or inactivation and 
current density of the CaV2.1 in the Purkinje neuron with normal or 
expanded polyglutamine. Similarly, Watase et al (2008) has also 
suggested that neither voltage dependent activation nor inactivation 
was altered in the SCA 84Q expanded neurons and the mice 
expressing hyper expanded polyglutamine developed progressive 
motor impairment and aggregation of mutant CaV2.1 channels.  
CaV1.2 plays an important role in calcium signals in multiple tissues, 
including brain, heart, smooth muscle cells and endocrine system. At 
least 20 of 56 exons of CaV1.2 are subject to alternative splicing. It is 
shown that the CaV1.2 in varies tissues are linked with specific splicing 
variants, which contributes to the functional diversity of CaV1.2. Studies 
reported that the CaV1.2 in smooth muscle were more susceptible to 
inhibition by dihydropyridines than CaV1.2 in cardiac forms and CaV1.2 
channels in smooth muscle exhibit hyperpolarized shift in activation 




combination of splicing pattern with (1/8/9*/32/∆33) while the cardiac 
form of CaV1.2 is (1/8/9*/32/33) (Liao et al 2004, Tang et al 2004). 
Recent studies have found that the alternative splicing of CaV1.2 is 
associated with Timothy Syndrome. Patients of Timothy Syndrome 
have severe cardiac arrhythmia and neurological disorders. The point 
mutations were found in the mutually exclusive exon 8 or 8a, which 
encode the IS6 region close to I-II loop region. The mutation on cardiac 
exon 8a has a severe consequence and delay the voltage-dependent 
inactivation, however, the mutation on neuronal type exon 8 exhibit 
much less phenotype. It is shown that exon 8a is highly expressed in 
heart, which explained the more severe consequence in heart than in 






Chapter 2 Splice-variant-selective modulation 





2.1.1 Alternative splicing of CaV2 
CaV2.1 exon 37a and 37b 
Bourinet et al (1999) and Soong et al (2002) have identified the splicing 
patterns of the rat and human CaV2.1 in brain. Seven splice loci have 
been identified. In the C-terminus, exon 37 is mutually-exclusively 
encoded by exon 37a and exon 37b, forming two splice variants of 
CaV2.1, named CaV2.1[EFa] and CaV2.1[EFb] (Bourinet et al 1999, 
Krovetz et al 2000). Other splice sites in the C-terminus of CaV2.1 
including exon 43/44, which could be either present or absent, 
generating four combinations (Soong et al 2002). At the end of the C-
terminus, there is an alternatively spliced insertion of GGCAG. With the 
insertion of the pentanucleotide, exon 47 could be translated in-frame 
to produce a longer isoform of CaV2.1. Otherwise, omission of 
pentanucleotide will result in a frame-shift and a pre-mature stop codon 
would appear to produce the short-form of CaV2.1 (Toru et al 2000, 
Zhuchenko et al 1997). 
In the proximal C-terminus of the VGCC, two EF-hand like domains are 
identified in L-type calcium channel and other VGCCs. Unlike classical 
EF-hand domain, the EF-hand in VGCC might not bind Ca2+ (de Leon 
et al 1995, Peterson et al 2000). Recent studies suggested that the EF-
hand like domain of VGCC is involved in binding to calmodulin. The 




(Adams et al 2014). Upon Ca2+ influx, the calmodulin translocates to 
bind the IQ motif.  
The C-terminus of CaV2.1 channels modulate channel properties 
including Ca2+-dependent inactivation (CDI) and Ca2+-dependent 
facilitation (CDF) ().  
The EF-hand like domain of the CaV2.1 and CaV2.2 channels are 
different in that they are encoded by a pair of mutually exclusive exons. 
The exon 37 is mutually exclusively spliced to generate either exon 37a 
or exon 37b in the two calcium channels. Several reports have 
indicated the functional differences of these two splice variants, 
CaV2.1[EFa] and CaV2.1[EFb]. The CaV2.1 channels undergo dual 
modulation upon Ca2+ influx in different fine-tuning Ca2+-dependent 
processes such as CDF (τ~ 10 ms) and CDI (τ~ 100- 500 ms) which 
influence synaptic plasticity in the nervous system (DeMaria et al 2001, 
Lee et al 2000). Both CDF and CDI have been reported to cause short-
term facilitation and depression of synaptic transmission respectively 
(Borst & Sakmann 1998). It is shown that CDF is associated with local 
calcium signal, which is mediated by N-lope of CaM, whereas the CDI 
is mediated by C-lope of CaM and distal calcium signal (Chaudhuri et 
al 2004). Interestingly, CaV2.1[EFa] channels with exon 37a could 
display both the CDI and CDF properties, whilst the mutually exclusive 
exon 37b-containing CaV2.1[EFb] channels only displays CDI 




cause more Ca2+ influx with a pre-pulse and may affect the plasticity of 
synaptic transmission (Adams et al 2010). 
During development, there is an expression-switch between EFa and 
EFb: EFb variant is expressed predominantly in early development in 
the fetal rodent brain, and a developmental switch occurred in the first 
2-3 weeks after birth when the expression of EFa is increased 
significantly. A similar scenario is also found in human brain where 
there is also more EFb variant in the fetal, while in adult brain, there is 
about a equal distribution of the two variants (Chang et al 2007). 
The EFa and EFb variants of CaV2.1 showed functional diversity and 
distinct expression patterns. The physiological role of these two splice 
variants has not been well studied. It will be interesting to determine 
how these two splice variants could contribute to the synaptic 
transmission and to determine whether there are some proteins that 
may modulate their functions. 
CaV2.2 exon 37a and 37b 
The CaV2.2 channel is another voltage-gated calcium channel found at 
the presynaptic terminal that is involved in synaptic vesicle release 
(Wheeler et al 1994). Other than CaV2.1, CaV2.2 channels are also 
highly concentrated in the sensory neuron in the dorsal root ganglion 
and spinal dorsal horn and they play a vital role in pain processing. The 
CaV2.2 channels can also be subject to alternative splicing including 
the EF-hand and two splice variants, CaV2.2[EFa] and CaV2.2[EFb], 




exclusively expressed in NaV1.7-positive neurons and its expression is 
correlated with higher CaV2.2 current density in nociceptive neurons 
compared to the neurons that expressed CaV2.2[EFb] (Bell et al 2004). 
The Zamponi’s group has shown that only CaV2.2[EFa] mediates 
thermal and mechanical nociception. Intrathecal injection of specific 
siRNA to knockdown CaV2.2 could effectively relieve pain in mice 
(Altier et al 2007). Furthermore, studies have provided evidence to 
support that why CaV2.2[EFa] is more effective in pain processing than 
CaV2.2[EFb] channels. It has been shown that CaV2.2[EFa] channels’ 
open time is longer than CaV2.2[EFb] as assessed by single channel 
recordings, and therefore CaV2.2[EFa] yielded larger current density as 
compared to CaV2.2[EFb] (Castiglioni et al 2006). The CaV2.2[EFa] 
channels have higher surface expression as compared to CaV2.2[EFb] 
channels, because exon 37b could be preferentially ubiquitinated and 
therefore more prone to degradation. Mutation of the Y1747 to F1747 
in exon 37 promote ubquitination and results in reduction of 
CaV2.2[EFa] current density. (Marangoudakis et al 2012). As such, 
CaV2.2[EFa] has an advantage for pain processing for its higher 
conductivity and resistance to ubquitination.  
CaV2.2 is shown to be modulated by G-protein in both a voltage-
dependent and a voltage independent way. The prominent effect of 
CaV2.2[EFa] is also shown by G-protein dependent modulation. 
Approximately 0.2-0.3 mM of GTP-γS could inhibit both CaV2.2[EFa] 
and CaV2.2[EFb] and this inhibition could be relived by pre-pulse 




specific to CaV2.2[EFa]. However, there is additional inhibition on 
CaV2.2[EFa] that could be compensated by pre-pulse activation. These 
voltage-independent inhibitions are dependent on pp60c-src tyrosine 
kinase and are associated with μ-opioid or GABAB receptors. The 
unique tyrosine 1747 in CaV2.2[EFa] might be a potential target for 
phosphorylation by pp60c-src tyrosine kinase and be involved in G-
protein dependent inhibition of the CaV2.2 channels (Raingo et al 
2007). 
2.1.2 CaV2 and vesicle release 
Voltage-gated calcium channels play a crucial role in mediating the 
evoked neurotransmitter release upon an action potential. Most of the 
synapses in the central nervous system rely on CaV2.1 and CaV2.2 
channels (Wheeler et al 1994).  
Synaptic proteins interaction at synprint modulate VGCC function 
It has been established that SNAP-25 (synaptosome-associated 
protein 25) and syntaxin interact with the synprint sites of CaV2.1 and 
CaV2.2 channels (Rettig et al 1996, Sheng et al 1996, Sheng et al 
1994). Interaction between VGCC and vesicle release machinery 
promote the voltage-dependent inactivation of channel and G protein 
regulation (Bezprozvanny et al 1995, Jarvis & Zamponi 2001). It was 
reported that synprint peptide could compete with the native synprint 
site in CaV2.1 and suppress the vesicle release in the chromaffin cell 




is associated with synaptic release and human diseases (Simms & 
Zamponi 2014, Weiss & Zamponi 2012).  
One CaV2.1 channel splice variant that does not contain the synprint 
site has been reported in some neuroendocrine cells. This splice 
variant that lacked most of the synaptic protein-binding site showed 
reduced Ca2+ current and the inactivation potential of the variant was 
also shifted to the hyperpolarized direction. The CaV2.1 mutation 
associated with human migraine, E1015K, has been found in the 
synprint site. The E1015K mutant channels displayed increased Ca2+ 
channel current because the SNAP-25 did not bind to the mutated 
synprint site in E1015K CaV2.1 channel (Condliffe et al 2013) 
VGCC localization in the presynaptic terminals and active zone  
The VGCCs convert the electrical input of action potential into chemical 
output of neurotransmitter release. The synaptic vesicle release is 
mediated by specialized regions in the presynaptic site called the 
active zones (Augustine et al 2003, Wojcik & Brose 2007). The 
synaptic vesicle machinery and calcium channels are docked at the 
active zones. The CaV2.1 and CaV2.2 channels are both localized in 
the active zones and the relative positions for CaV2.1 and CaV2.2 are 
fixed (Cao & Tsien 2005, Cao & Tsien 2010, Jun et al 1999).  
Many proteins were reported to regulate the localization of calcium 
channels such as Mint-1 and CASK (Maximov & Bezprozvanny 2002, 
Spafford et al 2003). The Sudhof’s group has shown that RIM proteins 




have decreased Ca2+ influx and reduced primed vesicles. Two domains 
of the RIM proteins tether the presynaptic Ca2+ channels to the active 
zones. One is the PDZ domain of RIM and it directly binds to the C-
terminus of channels. The PDZ domain of RIM has no selectivity for its 
binding to either CaV2.1 or CaV2.2 channels (Deng et al 2011, Han et al 
2011, Kaeser et al 2011). The other is the PXXP domain of RIM.  This 
domain interacts with RIM-binding protein and the presynaptic scaffold 
protein Bassoon, which specifically recruits CaV2.1 but not CaV2.2 
channels to the active zones (Davydova et al 2014).  
2.1.3 Functions of snapin  
Snapin is one of the critical proteins involved in the presynaptic 
complex important for neurotransmission. It has been identified to 
interact with many proteins in the axon terminals to affect vesicle fusion 
and transmitter release. Snapin was first identified as a SNAP-25 
binding protein. Human and rodent snapin share about 98% protein 
sequence identity (Ilardi et al 1999). 
Structures of snapin (coil-coil domain, phosphorylation site and 
dimerization) 
Snapin has a short hydrophobic N-terminus and a cytosolic C-terminus. 
The hydrophobic N-terminus is likely to be responsible for attachment 
to the vesicle membrane. The C-terminus is predicted to form a coil-coil 
domain and is the critical binding region for SNAP-25 and 




Snapin could be phosphorylated at Ser-50 and Thr-117. 
Phosphorylation at Ser-50 has been shown to increase the binding 
between snapin and SNAP-25. Overexpression of S50D, which 
mimicked phosphorylated snapin led to increase in the readily-
releasable pool of synaptic vesicles in chromaffin cells and in cultured 
primary neurons, while the S50A mutant snapin, which lacked the 
phosphorylation site, resulted in reduced number of readily-releasable 
pool number (Chheda et al 2001). In addition to Ser-50, recent studies 
have identified Thr-117 as another phosphorylation site of Leucine-rich 
repeat kinase 2 and phosphorylated snapin at Thr-117 decreased the 
interaction between snapin and SNAP-25 leading to instability of the 
VAMP2-syntaxin-SNAP25 complex. Thus, snapin phosphorylation at 
Thr-117 reduced the readily releasable pool and the extent of vesicle 
release (Yun et al 2013). Snapin might also be phosphorylated by 
Casein kinase 1 delta (CK1δ), while the exact phosphorylation site has 
not yet been found (Wolff et al 2006).  
Snapin has been shown to function as a dimer, formed through 
disulfide bond linkage at Cys-66. Snapin mutant C66A that disrupts 
dimer formation has a low affinity for binding to syt-1 and SNAP-25. 
Further studies have suggested that snapin could form tetramers in 
solutions. Snapin will preferentially form dimer when interacting with 




Snapin and synaptic transmission 
Neurotransmitter release is triggered by presynaptic Ca2+ influx (Meir et 
al 1999, Stanley 1997). The major Ca2+ sensor for fast vesicle release 
has been shown to be synaptotagmin I (Syt-I) (Zhang et al 2002a). 
Upon Ca2+ influx, Syt-I interacts with SNARE complex to trigger vesicle 
fusion (Chapman 2008). Biochemical studies have shown that snapin 
interact with both SNAP-25 and Syt-I (Ilardi et al 1999, Tian et al 2005). 
These interactions stabilize the Syt-I-SNARE complex. The chromaffin 
cell from snapin knockout mice showed reduced exocytosis burst and 
could be rescued by snapin overexpression in the snapin-deficient cells 
(Tian et al 2005). It has been demonstrated that snapin-deficient mice 
did not affect the basal expression level of the three SNARE complex 
components and Syt-I. But the interaction between Syt-I and SNARE 
was reduced, resulting in suppressed vesicle release. Further reports 
have indicated that snapin is involved in synchronizing synaptic vesicle 
fusion. Upon high-frequency stimulus of 50 Hz, snapin-deficient 
neurons do not maintain precision and efficacy as the wild-type 
neurons do (Pan et al 2009). Before Ca2+ influx, it is believed that 
snapin help to stabilize the apoSyt I-SNARE, when the apoSyt-I does 
not sense Ca2+. In snapin deficient cells, Syt-I is disassociated with 
SNARE and the presynaptic machinery could not respond to the 
transient Ca2+ that was elevated upon with in high-frequency stimulus 









Figure 1.3 Model of presynaptic machinery. 
The drawing illustrates the VGCC, snapin, SNARE complex (composed SNAP-25 
and 
Syntaxin-1 on the plasma membrane and synaptobrevin linked with synaptic vesicles) 
and Ca2+ sensor synaptotagmin-1. Snapin forms a dimmer and has been shown to 





Snapin and protein transport 
In addition to the critical role synchronizing vesicle release, snapin also 
mediates retrograde transport through binding with dynein. It has been 
shown that the transport of late-endosome from the distal axon terminal 
to soma was significantly impaired in snapin-deficient neurons, 
resulting in the accumulation of endosome and apoptosis of the cells. 
The motor protein dynein binds the snapin DIC domain (Cai et al 
2010). The retrograde transport system has been shown to be involved 
in several pathological conditions. For example, snapin-dynein 
machinery mediates transportation of β-site amyloid precursor protein 
cleaving enzyme and facilitate amyloid precursor protein processing 
(Ye & Cai 2014). Up to now, several proteins has been reported to 
transported via the snapin-dynein machinery, including TRPM7, BDNF-
TrkB and TMPAP (Krapivinsky et al 2006, Quintero et al 2013, Zhou et 
al 2012). 
2.1.4 Objectives and rationale 
The proximal C-terminus of VGCCs contains elements that are 
important for Ca2+-dependent regulatory processes such as CDI and/or 
CDF. Two CaV2.1 splice variants CaV2.1[EFa] and CaV2.1[EFb] have 
functional differences in eliciting Ca2+ dependent facilitation that will 
affect synaptic transmission (Chaudhuri et al 2004, Chaudhuri et al 
2007). The spatial and temporal expression patterns of CaV2.1[EFa] 
and CaV2.1[EFb] might influence Ca2+ influx and synaptic function 




differences of these two variants of CaV2.1 have not been fully 
elucidated. It is interesting therefore to investigate how these splice 
variants contribute to synaptic function and whether there is any factor 
that could preferentially modulate their functions. 
From our work, we have first identified using yeast-two hybrid assay 
that snapin interacts with CaV2.1 exon 37b that was used as bait. From 
biochemical and functional characterizations, we have discovered that 
snapin preferentially bind to CaV2.1 exon 37b than to exon 37a. Snapin 
is one of SNAP-25 binding proteins found in the presynaptic terminal 
(Ilardi et al 1999), and is involved in synchronizing synaptic vesicle 
fusion (Cai et al 2010), In addition, snapin mediated retrograde 
transport by interacting with dynein (Pan et al 2009). Here, we aimed to 
examine the interaction between CaV2.1 and snapin by biochemical 
and electrophysiological methods. Firstly, we determined the binding 
region between snapin and CaV2.1. Secondly, we examined the 
functional effect on CaV2.1 upon binding of snapin. Thirdly, we strived 
to examine the potential impact on the synaptic transmission upon 




2.2 Materials and methods 
2.2.1 Materials 
The experiments were carried out on C57BL mice as approved by NUS 
IACUC. The full-length human CaV2.1[EFa, 47-], CaV2.1[EFb, 47-], and 
CaV2.1[EFb, 47+]  subunits were reported in previous studies (Chang 
et al 2007, Soong et al 2002).CaV2.2[EFa] and CaV2.2[EFb] were 
reported in Lipscombe’s group (Bell et al 2004, Castiglioni et al 2006). 
2.2.2 Construction of snapin plasmids 
The human snapin is amplified from human brain cDNA library 
(Marathon-Ready Clontech, CA) and Elongase DNA polymerase (Life 
Technologies, CA) using  
Snapin-Fw ATGGCGGGGGCTGGTTCC 
Snapin-Rs- TTATTTGCCTGGGGAGCCAG 
-for a 411 bp amplicons, according to the standard PCR procedure for 
Elongase DNA polymerase. 
The PCR protocol for cloning the snapin using Elongase is  
Pre-denaturation 95°C  5 min 
Denaturation  95°C 30 sec 
Annealing  62°C 30 sec 




Repeat for 35 cycles 
Final extension 68°C for 5 min 
Snapin amplicons were sub-cloned into pGEM®-T Easy vector 
(Promega, WI) and the ligation products were transformed into DH10B 
E.coli. The snapin sequence was confirmed by sequencing according 
to AF086837. 
Subsequently, a myc tag were add on the N-terminals of snapin by 





The PCR products were double digested by BamHI and EcoRI, and 
subcloned into pIRES-DsRed2 expression vector (PT3775-5).  
The standard digestion reaction were performed for 2 hour incubation 
at 37°C as suggested by the manufacturer (New England Biolabs, MA). 
The digested product were purified using agarose gel electrophoresis 
and Gel Extraction Kit (QIAGEN, Germany). The DNA fragment were 
ligated at 16 °C overnight by T4 ligase (New England Biolabs, MA) and 




Snapin-C66A mutation was generated by site directed mutagenesis 
(QuickChange II Xl site-directed mutagenesis kit, Stratagene) 
employing the two complimentary primers  
C66A forward   AGCCACAGAACTGGCCCGCATAAATGAGGATC 
C66A reverse  GATCCTCATTTATGCGGGCCAGTTCTGTGGCT 
The snapin-C66A was sub-cloned into pIRES-DsRed vector as 
previously described.  
2.2.3 Construction of exon 37a/37b chimeras and GST fusion 
proteins 
The GST-fusion protein with EFa and EFb fragment were generated by 
cloning the proximal C-terminus of CaV2.1 with exon 37a or exon 37b 
into the pGEX4T1 vector. The 300 bp amplicons spanned from the end 
of IV-S6 segment  (part of exon 35) to exon 38 as indicated in the 
alignment of 2.9. The fragments included the two predicted EF-hand 
like domain but did not contained IQ domain. The PCR were performed 
using two following primers 
hA1A-C ter EcoRI  GGAATTCATGGACAACTTTGAGTACC 
hA1A-exon38SalI-sh GCGTCGACTCATCCCTTGGCAATCTT 
using the standard touch down PCR procedures. 
The PCR protocol for cloning the snapin using GoTag was  




Denaturation  95°C 30 sec 
Annealing  59°C to 53°C decrement  
and 53°C for the rest cycle 
Extension  72°C 30 sec 
Repeat for 35 cycles 
Final extension 72°C for 5 minutes 
The annealing temperature may vary in different studies and the 
extension time would be extended for longer fragments (1kb/min). 
The PCR products of EFa and EFb fragment were double digested with 
EcoRI and SalI and ligated with pGEX4T1 vectors.  
Three chimera constructions of exon 37a/37b were generated by 
overlapping PCR (Fig. 2.2). The overlapping complementary primer 
pairs spanned the exon 37a and exon 37b sequences. Two pairs of 
PCR reaction with upstream and downstream primer amplified the 1/3 
of up-streaming exon 37a and down-streaming 2/3 of exon 37b. These 
two DNA fragments were joined with denaturing by 95 for 5 min 
followed by slowly annealing in room temperature for 4 hours.  
The complementary primer pairs for chimera 1  





hA1A-hybEFa-0.3EFb re  
CCACTCTGGCCGGACATTTCTTGCCTA 





were used for overlapping PCR. 
The chimera 3 with (37b-37a-37b) was generated from EFb and 





The overlapping PCR products for hybrid EFa and EFb were 
subsequently amplified by the PCR using hA1A-Cter-EcoRI and 
hA1A-exon38SalI-sh. The chimeras of CaV2.1 were sub- cloned into 
pGEX4T-1 by EcoRI/SalI as previously stated. The CaV2.1 mutations, 
CaV2.1[WMPL-AAAA], CaV2.1[MPL-AAA], CaV2.1[W-A], CaV2.1[M-A], 




Cheng. The GST-fusion proteins with the EF-hand domains of CaV2.1 
mutations were cloned in pGEX4T-1 similarly as previously described.  
2.2.4 GST pull-down assays and western blot 
GST pull-down assays were conducted by using glutathione sepharose 
beads (GE-Health UK) to isolate the purified GST fusion protein linked 
with fragment of CaV2.1 (EFa/EFb and chimeras) and examine the 
interaction between snapin and proximal C-terminus of CaV2.1 (Wang 
et al 2011). 
The GST-fusion protein was prepared using isopropyl β-D-1-
thiogalactopyranoside (IPTG) induction system. The plasmids were 
transformed into BL21 E. coli. The bacterial was cultured in 200 ml LB 
media in 37°C until the O.D. value reached 0.8-0.9, before adding 
isopropyl IPTG (0.5 mM). After 5 hours of induction in 30°C, the 
bacterial was spun down by 6000 rpm for 20 minutes and washed with 
PBS. The bacterial pullets were suspended with 10 ml of PBS with 1% 
Triton X-100 and 1X proteinase inhibitor (Roche). After sonication for 5 
minute, the bacterial lysis was spun down in 13,000 rpm for 30 min and 
the supernatant with GST-fusion protein was incubated with glutathione 
sepharose beads 3 hours at 4°C. GST-beads were washed with PBS 
for more than 5 times and stored in -20°C. 
The immobilized GST fusion proteins were incubated with HEK 293 cell 
lysis with transfected snapin for 1h at 4°C. After washing with PBS for 3 
times, glutathione-bound proteins were eluted by boiling at 95°C in 




with anti-snapin (SYSY; 1:1000 dilution) or anti-GST (Santa Cruz; 
1:5000 dilution) antibodies. 
Total protein for western blot was extracted from culture cell in RIPA 
buffer. The protein concentration was measured by Bradford assay 
(Bio-Rad). Protein samples were denatured at 95°C for 5 minutes in 
5XSDS-sampling buffer with 2-mercaptoethanol. The SDS-PAGE was 
performed using 8% to 12% polyacrylamide gel. Equal amount protein 
were loaded for SDS-PAGE, The protein was electrically transferred to 
polyvinylidene difluoride (PVDF) membranes (Millipore) using standard 
transfer buffer.  
The PVDF membrane was then blocked by 5% milk in Tris-Buffered 
Saline and Tween 20 (TBST) buffer and incubated with primary 
antibodies overnight at 4°C and following HRP-linked secondary 
antibody for 1 hour at room temperature (Sigma, 1:5000 dilutions). The 
blots were visualized with either Pierce ECL Western Blotting Substrate 
or SuperSignal West Pico Chemiluminescent Substrate enhanced 
(Thermo Scientific, IL) before exposing to an X-ray film (Kodak).  
2.2.5 Mammalian cell culture and transient transfection  
Human embryonic kidney (HEK) 293 cell were maintained in 
Dulbecco's Modified Eagle Medium (DMEM) with 10% fetal bovine 
serum (FBS) and grown in 37°C incubator with 5% CO2. 1% Pen/strip 
were added to avoid contamination. All the culture media were from 




80-90% confluency. The cells were plating in 4-6 X104 cells/cm2 each 
time.  
Transient expression of calcium channel in HEK293 cell for 
electrophysiology 
For cell transfection by electrophysiological studies, HEK cell were 
seeded on 12 mm X 12 mm poly-D-lysine coated coverslips in 35 mm 
culture dishes. The seeding density was low with approximately 1X104 
cells/cm2 and therefore, isolated cell would be available in further whole 
cell patch clamp studies. The cells were incubated for 16-24 hours to 
ensure the cells are attached to the coverslips. The growth media are 
aspirated and replaced with fresh media without antibiotics one hour 
before transfection. Calcium phosphate transfection was applied to 
transient expressing the voltage-gated calcium channel and pIRES-
DsRed-snapin or snapin-C66A (1 μg) for patch clamp studies. The 
pIRES-DsRed was used as transfection control for the following 
studies. Approximately equal-molar ratio of α1 pore-forming units (1.7 
μg), β2a (1.25 μg) and α2δ1 (1.25 μg) DNA plasmid as well as T-antigen 
(0.25 μg) were mixed with 75 μl of CaCl2 and 75 μl of 2XHBS buffer 
(280 mM NaCl, 50 mM HEPES and 1.5 mM NaH2PO4). 
The rat β2a and rat α2δ1 subunit clones were reported in previous 
studies (Liao et al 2007, Tang et al 2008). The mixture was incubated 
in room temperature for 15-20 minutes to allow the DNA-calcium 
phosphate precipitate to form. We gently added the mixture into culture 




Calcium phosphate precipitant could be found 3-5 hours after 
transfection. Afterward, fresh DMEM media without antibiotic were 
applied to remove the transfection reagent. The cells were maintained 
for 36-72 hours for electrophysiology studies. Noted that the β2a was 
cloned into pIRES-AcGFP vector and snapin was cloned pIRES-DsRed 
vector. The appearance of GFP and DsRed in cells indicated that the 
calcium channels and snapin were both expressed in cells.  
Transient expression in HEK293 cell by lipofectamine 
For HEK cell transfection for biochemical studies, the HEK cell were 
transfected using lipofectamine™ 2000 (Life Technologies). The cells 
were reach 90% confluency before transfection. One hour before the 
transfection, the used media was aspirated and fresh media without 
antibiotics was introduced. 4 μg of plasmid DNA and 10 μl of 
lipofectamine™ 2000 were diluted in 250 μl of Opti-MEM® I Reduced 
Serum Media separated. After 5 min incubation, we mixed the DNA 
plasmid and lipofectamine and incubated in room temperature for 30 
minutes to allow the DNA-lipofactamine mixture form. The mixture was 
then added into the cell culture. After 5-6 hours, the spent media with 
transfection reagent was aspirated and replaced with fresh media 
without antibiotics. The cells were grown for 24 hours before harvested. 
2.2.6 Primary hippocampal neuron culture 
The primary hippocampal neuron was prepared according to establish 
protocols (Kaech & Banker 2006). The mice hippocampal neurons 




The astroglial feeder was prepared from P1 mice cortex 2 weeks 
before the neuron culture. The cortex was separated from mice pups 
and the meninges were removed carefully with forceps to avoid 
fibroblast cell contamination. The brain tissue was washed by 
dissecting solution (Hank's Balanced Salt Solution, HBSS with 10 mM 
HEPES) and cut down into small pieces After dissociated by 0.25% 
trypsin (Life Technologies) and 1% DNase (Roche), the brain tissues 
were triturated by pipetting the solution and filtered through cell strainer 
(BD). The cells are plating in 1.5X105 cell/cm2 with glial medium (Basal 
Medium Eagle, 10% Horse Serum, 1% Pen/Scripts, 1 X GlutaMax, and 
1 μM Sodium Pyruvate, 1 mM HEPES, 0.6% glucose). The media were 
changed 1 day after the plating and every 3 days later. The astroglial 
feeder would reach about 20-40% confluence before neuron culture.  
The hippocampi or cortex were dissected from P0 mice. The meninges 
were carefully removed and the hippocampi was digested by 0.25% 
trypsin and 1% DNase (Roche) in HBSS for 15 minutes. The 
hippocampi were then washed by HBSS to removed trypsin and the 
tissue is dissociated by pipetting the solution with polished tips. The 
dissociated neurons are plated on poly-D-lysine-treated (Sigma) 
coverslips (Marienfeld, Germany) with neural plating medium (Basal 
Medium Eagle, 10% Horse Serum, 1 X GlutaMax, 0.6% glucose and 1 
mM HEPES) for 3 hours. The cultured neuron were supported by 
astroglial feeder and maintained in neural basal medium with B27 




final concentration of 5 μM to inhibit glial proliferation. All media were 
obtained from Life Technologies. 
2.2.7 Lentivirus preparation and transduction on neurons 
ShRNA to snapin was packaged using ViraPower™ Lentiviral 
Expression Systems (Life Technologies CA). HEK 293FT cells were 
maintained according to standard procedures by DMEM and FBS. The 
viral plasmid were transfected to the HEK 293FT cells, when it reach 
90-95% confluence (10 cm dishes). The viral plasmid pLP1 (3 μg), 
pLP2 (3 μg) and pLP-VSVG (1 μg) as well as shRNA plasmid (3 μg) 
were diluted in Opti-MEM media and then mixed with 25μl of 
lipofactamine 2000. After 30 minutes of incubation, the mixture was 
added into cell culture. Fresh media was added to replace the media 
with transfection reagent.  
The virus-containing supernatants were harvested two times at 48 and 
72 hours post-transfection by transferring the medium into to a 50 ml 
sterile, capped, conical tube. 
The supernatants were spin down at 3000 rpm for 15 minutes at 4°C to 
remove pellet debris and filtered through Millex-HV 0.45 μm. The viral 
containing supernatants were spin down at 30,000 rpm for 2 hours at 
4°C using ultra-centrifuge. The viral pellet could be found in the bottom 





In order to determine the tittering ratio for lentivirus, the cells were 
plating about 30–50% confluent 1 day before transduction. The 
lentiviral stock was thawed and 10-fold serial dilutions of lentiviral stock 
ranging from 10-2 to 10-6 were prepared and added in to cell culture. 
One day after the transduction, the media-containing virus was 
replaced with fresh DMEM and incubates for 48-72 hours before 
fixation. The titer rated was determined by counting the transfected 
cells with fluorescence versus total cell number.  
Transducting the lentivirus in primary neuron. 
The primary neurons were cultured for DIV7 before transduction. 20 ul 
of lentiviral stocked was diluted in to and added in to final volume of 1 
ml in the neuron culture media. The media with virus was removed and 
replaced with 1 mL of complete culture medium. 
2.2.8 Snapin shRNA  
Snapin-shRNA vectors with GFP tag and control vector were 
purchased from Sigma. (TRCN0000176557, TRCN0000277451, 
TRCN0000277452, TRCN0000277457, TRCN0000277- 526 and 
SH003), targeting on the coding sequence of snapin.  
2.2.9 Whole cell patch-clamp electrophysiology on mammalian 
cell culture and primary neuron  
Whole cell patch-clamp recording on HEK293 cell channel were 
performed within 36-72 hours after the calcium phosphate transfection. 




CaCl2 or 5 BaCl2 (pH was adjusted to 7.4 with TEA-OH and osmolarity 
was adjusted to 300-310 mOsm with glucose). The pipette solution for 
recording CaV2.1 and CaV2.2 channel current contained  (in mM) 10 
HEPES, 5 CsCl, 138 Cs-MeSO3, 0.5 EGTA, 1 MgCl2, 2 mg/ml MgATP, 
pH 7.3 (adjusted with CsOH), Osmolarity is between 290 and 300 
mOsm.  
The borosilicate glass pipette (WPI, FL) were prepared using P97 
(Sutter, CA) and polished with microfuge (Narishege, Japan). The 
pipette solution is backfilled in the glass pipette. The resistance of 
glass is within 1.5-2 MΩ.  
The 293 cells were held at -90 mV by voltage clamp using Axopatch 
700B or Axopatch 200B (Molecular Devices, CA). The series 
resistance for recording was typically less than 5 MΩ, 70-80% 
compensation on serial resistance and cell membrane capacitance was 
applied. A P/4 protocol was applied to subtract the leakage current. All 
data are obtained with Digidata 1440A (Molecular Devices, CA), 
sampled at 5-50 kHz. The 1 kHz or 6 kHz low pass filter are applied for 
all the data.  
In order to study the activation threshold of voltage-gated calcium 
channel, we performed the studies using tail protocol, which represent 
the conductivity of channel. Cells were depolarized to a serials of 
voltages, ranging from -60 to 100 mV, in steps of 10 mV increments, 
for 20 ms. Following the depolarization, a -50 mV step for 10 ms 




maximum current obtained from each cell and fitted through single 
Boltzmann equation: 
ܩ	 ൌ 	ܩ௠௜௡ ൅	ሺܩ௠௔௫ 	െ	ܩ௠௜௡ሻ ሺ1 ൅ ݁
௏భ/మೌ೎೟	ି	௏
௞ೌ೎೟ ሻ⁄  
where G represents the tail current, V is the membrane potential of the 
test pulse. The following parameters were determined by curve fitting. 
Gmax is the maximum tail current recorded from each cell, Gmin is the 
maximum tail current recorded for fitting curve. kact is the slope factor 
and V1/2act represent the voltage when the channel current reaches half 
of the maximum current. 
The current-voltage (I-V) relationships of voltage-gated calcium 
channel were studied by applying a serial of test potentials from -60 
mV to 40 mV with 10 mV increments to the transfected 293 cells during 
voltage clamp. The I-V relationships are fitted by the following 
equation: 
ܫ	 ൌ 	ܩ௠௔௫ ሺܧ௥௘௩ െ ܸሻ ሺ1 ൅ ݁
௏భ/మೌ೎೟	ି	௏
௞ೌ೎೟ ሻ⁄  
where I represents the current, V is the membrane potential of the test 
pulse. The Gmax represent the maximum conductance of the cell, V is 
the membrane potential of the test pulse, Erev is the reversal potential 
for the calcium channel, V1/2act represent the voltage when the channel 
current reach half of the maximum current and kact is the slope co-




Steady-state inactivation (SSI) properties were examined by comparing 
the test current to the initial pre-pulse. The pre-pulse current was 
evoked by to 0 mV voltage step for 30 ms. A long depolarizing pulse of 
15 seconds are applied to inactivate the calcium channel ranging from -
120 to 20 mV, with 10 mV increment. The test-pulse current was 
evoked by 0 mV voltage step for 100 ms. The test current was divided 
by the pre-pulse current. The values were fitted with a single 
Boltzmann equation: 
ܫ	 ൌ 	 ܫ௠௜௡ ൅ ሺܫ௠௔௫ െ ܫ௠௜௡ሻ ሺ1 ൅ ݁
௏భ/మ೔೙ೌ೎೟	ି	௏
௞೔೙ೌ೎೟ ሻ⁄  
where I is the normalized current for V is the membrane potential of the 
stead-state inactivation, V1/2inact represents the voltage when the 
channel current reach half of the maximum current and kinact is the 
slope co-efficient for the inactivation. Imax is the maximum tail current 
recorded from each cell, Imin is the maximum tail current recorded for 
fitting curve. 
Calcium dependent inactivation (CDI) was examined by stepwise 
voltage depolarization for 1 second. The whole cell current was 
obtained using Ba2+ or Ca2+ as charge carrier to distinguish the Ca2+ 
dependent component to voltage dependent component. This idea was 
derive from selective affinity of calmodulin to Ca2+ than Ba2+, From the 
initial holding of -90 mV, a family of depolarization steps from -60 mV to 




The fraction of inhibition was calculated by the remaining current after 
300 ms (r300) or 800 ms (r800) recorded in Ba2+ or Ca2+. The r300 and 
r800were plotted against the voltage. The curves for CDI were fitted by 
nonlinear poly regression. The pure calcium dependent inactivation, f-
index was obtained from deducting the r300 or r800 recorded in Ca2+ 
from that Ba2+ in 10 mV.  
Calcium dependent facilitation (CDF) of CaV2.1 was elicited by a step 
depolarization followed by a family of pre-pulse (-80 mV to 60 mV with 
20 mV increments) recorded in Ba2+ and Ca2+ solution, to distinguished 
the pure Ca2+ dependent component. It is known that the VGCC also 
under calcium dependent inactivation. In order to separate the 
facilitation (CDF) part from the inactivation component (CDI), we have 
exploited two crucial features. First, the kinetics for CDF is much faster 
than CDI, (CDF, 10 ms versus CDI, 100 ms to seconds). Second, the 
occurrence of CDI inactivated a portion of channels, leaving the other 
channels available for CDF. Therefore, the 20 ms pre-pulse was 
sufficient to induce CDF and short enough to minimize the inactivation. 
The diagram of the protocol was shown in figure 2.7.  
Without the pre-pulse, the normalized test pulse could be 
approximately described by the following equation: 
ܫ௡௢௥௠൫ݐ, 	௡௢௣௥௘൯ ൌ 	ܨ௙௔௦௧ ൅ ሺ1 െ ܨ௙௔௦௧ሻሺ1 െ ݁ି௧ ఛൗ ሻ 
where Ffast is the rapid fraction on the channel current and τ is the time-




After pre-pule, a relative fraction (RF) is the pre-pulse induced 
facilitation. Therefore, the normalized test pulse with pre-pulse was 
given by: 
ܫ௡௢௥௠൫ݐ, ௣ܸ௥௘൯ ൌ 	ܨ௙௔௦௧ ൅ ܴܨ ൅ ሺ1 െ ܨ௙௔௦௧ െ ܴܨሻሺ1 െ ݁ି௧ ఛൗ ሻ 
where RF is the pre-pulse induced fraction, and the trace is also 
dependent on the voltage of prepulse (Vpre). Therfore, we have 
integrated the difference value between normalized waveforms 
obtained with or without prepulse to obtain ∆Q. The ∆Q is shown by: 
∆ܳ ൌ 	න ሾܫ௡௢௥௠൫ݐ, ௣ܸ௥௘൯ െ ܫ௡௢௥௠൫ݐ, 	௡௢௣௥௘൯ሿ݀ݐ
ஶ
௧ୀ଴




Therefore, the value of Relative fraction (RF) is obtained from (total 
charge difference) ∆Q divided by trace decay time (τ). 
The τ was calculated by fitting the normalized curve to single 
exponential curve obtained in + 20 mV without pre-pulse. The ∆Q is 
calculated from the area difference with or without pre-pulse obtained 
in a family voltage steps. 
Whole cell patch-clamp recording on primary neuron were performed 
on DIV10-11. The external solution contained (in mM) 145 NaCl, 10 
HEPES, 3 KCl, 2 MgCl2, 2 CaCl2 and 8 glucose (pH was adjusted to 
7.3 with NaOH and osmolarity was adjusted to 300-310 mOsm with 
glucose). The glass pipette was back-filled and tip-filled with pipette 
potassium based solution contained 146.5 K-gluconate, 10 HEPES, 9 




7.3 with KOH, and osmolarity was adjusted to 290-300mOsm with K-
gluconate). The whole cell patch was performed using Axopatch 700B 
and obtained with Digidata 1440A. At least 5 minutes after forming the 
patch, the spontaneous EPSC was record by gap-free protocol 
continuously for 8 minute, with sampling rate of (pCLAMP 10.2). The 
EPSC events were analyzed by MiniAnalysis (Synaptosoft, GA)  
2.2.10 Immunocytochemistry and confocal imaging  
For immunofluorescence on hippocampal neurons, the following 
antibodies were used, rabbit anti-MAP2 antibody (ab32454, abcam, 
UK, 1:100), mouse anti-synapsin antibody (106001, SYSY, Germany, 
1:100), rabbit anti-snapin antibody (148002 SYSY, Germany, 1:400). 
The following Alexa fluo dye conjugated with anti-IgG were used, Alexa 
is goat anti-rabbit Alexa 594 (1:400), anti-rabbit Alexa 488 and goat 
anti-mouse Alexa 594 (1:400) (Life Technologies, CA). 
The primary hippocampal neurons are stained and analyzed at DIV14-
16. The neuron are fixed by 4% paraformaldehyde PBS, pemeablized 
by 0.1% Trion-X and blocked with blocking buffer (5% goat serum and 
1% bovine serum albumin in PBS), Primary antibodies 
(MAP2/synapsin/snapin) were applied in PBS/BSA/Trixton at 4°C 
overnight and then incubated with the Alaxa-conjugated secondary 
antibodies for 1 h. The cells were washed by PBS and stained with 
DAPI for 10 min. The coverslip is mounted in Fluosave Reagent 




2.2.11 RNA extraction and RT-PCR 
The efficiency on of snapin knock down was detected by RT-PCR 
experiments. Total RNA from neuron was isolated using standardized 
Trizol methods (Invitrogen, Carlsbad, CA).  
The cDNA was synthesized with oligo (dT)18 primers and Superscript 
II reverse transcriptase (Life Technologies, CA). RT(-) control reaction 
without reverse transcriptase were performed in all RT reactions to 
exclude the possible contamination by genomic DNA. The subsequent 
PCR were performed by using primer. 




2.3.1 Snapin bound to proximal C-terminus of voltage-gated 
calcium channel 
Alternative splicing of exon 37 generates two splice variants 
CaV2.1[EFa] and CaV2.1[EFb] (Bourinet et al 1999, Chaudhuri et al 
2004, Krovetz et al 2000, Zhuchenko et al 1997). It has been shown 
that CaV2.1[EFa] channels conduct more Ca2+ than CaV2.1[EFb] 
channels. CaV2.1[EFa], but not CaV2.1[EFb] exhibits robust Ca2+-
dependent facilitation (Chaudhuri et al 2004, Chaudhuri et al 2007). It 
was also reported that the Ca2+ influx through CaV2.1 channels is 




& Momiyama 1993, Wheeler et al 1994). However, how the splice 
variants of CaV2.1[EFa] and CaV2.1[EFb] variants contribute to 
synaptic plasticity is still obscure. In order to expand on the functional 
diversities of the two CaV2.1 EF-hand splice variants, we screened for 
proteins that might preferentially modulate CaV2.1[EFa] or CaV2.1[EFb] 
function.  
Our laboratory has performed yeast-two-hybridization screening and 
we used bait sequence that spanned end point of IV-S6 to exon 38 with 
either exon 37a or exon 37b. Yeast-two-hybrid screening was done 
using the human brain library. Our work has shown that snapin, the 
SNAP-25 binding protein, could preferentially bind to exon 37b but not 
exon 37a.  
In order to confirm the interaction between snapin and exon 37b of 
CaV2.1, GST-fusion proteins containing either exon 37a and exon 37b 
of CaV2.1 were generated from clones harbouring the respective 
proximal C-terminus. The segments of proximal C-terminus of Cav2.1 







Figure 2.1 Alternative splicing of exon 37 in CaV2.1.  
A. The EF-hand like domain is in the proximal C-terminus of CaV2.1. Exon 36 and 
exon 37 (Yellow) form the first EF-hand. Another predicted EF-hand was shown close 
to the calmodulin-binding domain. B. Exon 37a and exon 37b are mutually 
exclusively expressed in CaV2.1. C. Alignment of amino acid sequences of human 
exon 37a and exon 37b. 
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Figure 2.2 GST-pull down assay showed preferential interaction between snapin and 
EFb variant of CaV2.1. 
 A. Alignment of amino acid sequences of EFa, EFb and their chimeras. B. 
Diagrammatic representation of the GST-fusion proteins include part of exon 35, 
exon 36-38 containing exon 37a, exon 37 b or exon 37a/37b chimeras (Ch). This 
segment of proximal C-terminus of CaV2.1 was cloned into pGEX4T-1 to generate 
GST-fusion proteins. C. Western blot analysis of GST pull-down assay indicates 
snapin has higher affinity of binding to EFb than to EFa fragment of CaV2.1. Snapin 
also preferentially pulled down GST-chimera 3. GST-chimera 2 had a relatively weak 


















































Using these GST-fusion proteins to pull down cell lysis containing 
snapin, we found that snapin preferentially bound to EFb fragment of 
Cav2.1, while there was a faint band of EFa detected. Therefore, 
snapin was preferentially bound to exon 37b compare to exon 37a of 
CaV2.1 (Fig. 2.2C). Further studies were performed to investigate the 
specific binding sites for snapin-CaV2.1 interaction. Among the 33 
amino acids of exon 37, there are 10 amino acid differences between 
exon 37a and exon 37b (Bourinet et al 1999). Therefore, we have 
generated a few chimeras of EF-hands by arbitrarily dividing exon 37 
into three segments as shown in figure 2.2A. Chimera 1 contained 2/3 
of exon 37a and 1/3 of C-terminus of exon 37b. Chimera 2 contained 
1/3 of exon 37a and 2/3 of C-terminus of exon 37b. Chimera 3 
contained 1/3 of N and C- terminus of exon 37b and the middle part is 
from exon 37a sequences. All the chimeras were cloned into GST-
expression vector, pGEX4T-1. The GST-pull down assays showed that 
chimera 3 bound snapin with the highest affinity compared to the other 
two chimeras. Chimera 2 had a weak interaction to snapin but the 
binding of snapin to chimera 1 was hardly detectable. These results 
suggested that the N-terminal segment of exon 37b is critical for 
binding with snapin. 
Four amino acids in N-terminal exon 37b are different from exon 37a. 
Therefore, we mutated these critical amino acids to alanine in the N-
terminal region of exon 37, i.e. tryptophan (W), methionine (M), proline 
(P) and lysine (L). The GST-pull down assay results showed that the 




AAA) resulted in a reduction in binding between snapin and EF-hand 
fragment (Fig. 2.3). Taken together, snapin preferably bound to exon 
37b of CaV2.1 and the amino acids in the N-terminal of exon 37b are 
critical for the binding of snapin.  
2.3.2 Snapin increased current density of CaV2.1[EFb] but not 
CaV2.1[EFa] channels 
We have shown the interaction between snapin and CaV2.1[EFb]. In 
order to investigate the functional effects of the interaction between 
snapin and CaV2.1, we have examined the possible attribution of  Ca2+ 
channel properties of CaV2.1[EFa] and CaV2.1[EFb] with snapin. 
Therefore, we co-transfected snapin and CaV2.1 into HEK 293 cells 






Figure 2.3 GST pull-down assays indicated that N-terminal region of EFb is important 
for binding of snapin. 
A. Several mutations of exon 37b were generated at the critical amino acids in exon 
37b, including WMPL-AAAA, MPL-AAA, W-A and L-A. The mutant EFb fragments 
were then cloned into GST-expression vector. B. GST-pull-down assay showed that 
MPL-AAA triple mutation suppressed the binding between snapin and EFb fragment. 
C. The relative pull down level was determined by western blot. * p < 0.01, compared 
between EFb and EFa, #, p < 0.05, compare with EFb. The data were represented as 






We first briefly examined the by current-voltage (I-V) relationships of 
snapin co-transfected with the CaV2.1[EFa] and CaV2.1[EFb] variants 
(Liao et al 2004). In this study, a family of depolarization steps were 
delivered to activate the voltage-gated calcium channel. To obtain 
results for current density, we divided the currents evoked by each 
potential by membrane capacitance, which represent cell surface area. 
The graphs were plotted on the relationships between the holding 
voltage and current density and the result showed that snapin 
increased the current density for CaV2.1[EFb] (CaV2.1[EFb] + vector 
50.97 ± 8.153 pA/pF, n = 19; CaV2.1[EFb] + snapin 89.06 ± 12.05 
pA/pF, n = 14, p = 0.015). But snapin did not affect current density of 
CaV2.1[EFa] recorded by I-V protocol.  
Further studies were performed using the tail protocol, which is a more 
accurate way to compare the current-voltage relationships. The tail 
protocol was generated by a family of 20 ms test-pulse (-60 mV to 100 
mV) and -50 mV repolarization, following each step. The results 
derived from using the tail protocol (Fig. 2.4) showed that snapin 
significantly increased the current density of CaV2.1[EFb] channels 
(from 157.8 ± 7.0 pA/pF, n = 15 to 222.5 ± 6.7 pA/pF, n = 22, p < 
0.001). In contrast, snapin did not affect CaV2.1[EFa] current density 
(Table 2.1).  It is known that the C-terminus of CaV2.1 undergo 
alternative splicing and amongst various splice variations could 
produce a long-form CaV2.1[47+] and short-form CaV2.1[47-] (Soong et 
al 2002, Zhuchenko et al 1997). In view of this, we also examined the 




increased current density of the long-form CaV2.1[EFb, 47+] even 
larger as shown in tail protocol (vector, -168.7 ± 6.2, pA/pF, n = 14; 
snapin, 283.9 ± 11.4 pA/pF, n = 24, p < 0.001) and I-V protocols 
(vector, 168.7 ± 6.2 pA/pF, n = 22; snapin, -108.2 ± 12.86 pA/pF, n = 
19, p = 0.028).  
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-7.65 ± 0.56 
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-22.80 ± 0.44 
(8) 
-22.79 ± 0.91 
(7) 
  
The number of experiments is indicated in parentheses. V1/2act and V1/2inact represent 
potential of half activation and half inactivation. V1/2act was derived from tail-activation 
curves recorder in Ba2+ solution and V1/2inact was derived from SSI recorded Ba2+ 
solution (Fig. 2.4). For statistics, * p < 0.001, compared with same group between 






Figure 2.4 Snapin enhanced current density of CaV2.1[EFb,47±] channels. 
 A. I-V curve properties of CaV2.1[EFa,47-], CaV2.1[EFb,47-] and CaV2.1[EFb,47+], 
with (red) or without snapin (black). Upper panel, exemplary traces of channel current 
were shown in 0 mV. Calibration bar: 1 nA, 100 ms. B. Channel current activated by 
tail protocol of CaV2.1[EFa,47-], CaV2.1[EFb,47-] and CaV2.1[EFb,47+] with (red) or 
without snapin (black). Upper panel, exemplary traces of the tail currents activated at 
-20 mV, +10 mV and +50 mV. Calibration bar: 1 nA, 10 ms. C. Activation curve and 
inactivation curve were obtained from a tail protocol and steady-state inactivation 
protocol. The two curves of CaV2.1[EFa,47-], CaV2.1[EFb,47-] and CaV2.1[EFb,47+] 
with (red) or without snapin (black) were plotted in the same chart. Upper panel, 
exemplary traces of the stead-state inactivation of normalization pulse and test pulse. 
Calibration bar: 0.5 nA, 100 ms. *p < 0.001. Each group was compared with and 
without snapin by Student t-test. 
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Together, the electrophysiological results indicate that snapin has a 
stronger effect on increasing the current density of CaV2.1[EFb, 47+] 
(68%) compared to the CaV2.1[EFb, 47-](41%). These results showed 
that snapin preferentially increased the current density on CaV2.1[EFb] 
but not on CaV2.1[EFa] through  preferential binding to exon 37b. In 
addition, the inclusion of exon 47 of the distal C-terminus augmented 
CaV2.1 current while interacting with snapin.   
In addition to current density, we compared the activation and 
inactivation threshold of CaV2.1 currents by examining the activation 
and inactivation potential using the Tail and steady-state inactivation 
(SSI) protocols. The activation curves were obtained from a tail 
protocol. The currents obtained at different depolarization steps were 
normalized to the peak current of each cell. By fitting with single 
Boltzmann equations, the activation curves is quantified by V1/2act, 
where, half of the channels were open at this voltage. The steady-
stated inactivation protocol was conduced by 15s depolarization with a 
family of voltage. The inactivation ratio was obtained from the ratio of a 
test pulse before and after this steady-state depolarization. The SSI 
results were also fitted with single Boltzmann equations and V1/2inact 
refer to the voltage, where half of the channels were inactivated. The 
interception of V1/2act and V1/2inact provide the window current for the 
VGCC (Liao et al 2009). Our results showed that snapin did not 
significantly affect either V1/2act or V1/2inact of CaV2.1[EFa] and 
CaV2.1[EFb] (Figure 2.4C and Table 2.1). These results suggested that 






Figure 2.5 Characterization of the interaction between mutant CaV2.1 and snapin.  
A. I-V curve properties of CaV2.1[EFb] WMPL-AAAA and CaV2.1[EFb] L-A and with 
(red) or without snapin (black). Upper panel, exemplary traces of channel current 
evoked at 0 mV. Calibration bar: 1 nA, 100 ms. C. Channel current activated by tail 
protocol of CaV2.1[EFb] WMPL-A and CaV2.1[EFb] L-A with (red) or without snapin 
(black). Upper panel, exemplary traces of the tail current activated at -20 mV, +10 mV 
and +50 mV. Calibration bar: 1 nA, 10 ms. D. Summary chart on the channel current 









































































The GST pull-down results have indicated that the N-terminus of exon 
37b is crucial for binding with snapin. The replacement the N-terminus 
of exon 37b and the MPL-AAA mutation of exon 37b disrupted the 
interaction between snapin and CaV2.1. We generated the full-length 
channel with MPL-AAA and chimera (1/3e37a+2/3e37b) and examined 
the electrical properties of the channel. However, these mutated 
channels were non-functional for unknown reason to us and as a result 
we could hardly record the channel’s current. Therefore, we have tried 
the WMPL-AAAA quadruple mutation by substituting tryptophan (W), 
methionine (M), proline (P) and lysine (L) of exon 37b into alanine and 
examined whether the current densities are altered in the mutant 
channels as compared to the wild-type reference CaV2.1[EFb] channel. 
Therefore we compared the function of WMPL-AAAA and L-A of 
CaV2.1[EFb] channels in their interaction with snapin. The data shows 
that WMPL-AAAA abolished the binding of snapin to CaV2.1 (WMPL-
AAAA + vector, 167.1 ± 10.3 pA/pF, n = 10; WMPL-AAAA + snapin, 
154.1 ± 5.8 pA/pF, n = 14; p = 0.25), while the L-A substitution partially 
impaired the functional effects of snapin binding (L-A + vector, 211.8 ± 
21.9 pA/pF; n = 8; L-A + snapin 271.9 ± 18.9 pA/pF, n =15; p = 0.053) 
(Fig. 2.5). These function results support the idea that snapin-CaV2.1 
interaction is dependent on exon 37b. 
Overall, our results suggest that snapin binds to the N-terminus of exon 
37b and increases the Ca2+ channel current. Mutations of the amino 
acids found on the N-terminal segment of exon 37b disrupted the 




mutations may disrupt channel functions. WMPL-AAAA of CaV2.1[EFb] 
mutant channels conducted normal current but they could not be 
modulated by snapin. Therefore, the interaction between snapin and 
CaV2.1[EFb] offer another level of splice-variant selective modulation to 
enhance Ca2+ influx via CaV2.1 channel. 
2.3.3 Snapin functioned as a dimer in modulating CaV2.1  
It has been reported that snapin forms dimer via disulfide bond of 
cysteine 66 (Pan et al 2009). In order to determine whether snapin 
dimerization affects the interaction between snapin and CaV2.1, we 
generated the snapin-C66A mutant by substituting the cysteine for 
alanine. As shown in figure 2.6A, the snapin-C66A mutants could not 
form dimers as examined under reducing conditions, without addition of 
2-mercaptoethanol in the preparation of protein samples for SDS-
PAGE. To examine whether the snapin-C66A proteins could still act on 
CaV2.1[EFb] channels as monomers, we co-expressed snapin-C66A 
with CaV2.1[EFb] in HEK 293 cells. We found that snapin did not 
increase the current density of the CaV2.1[EFb] (CaV2.1[EFb] + snapin-
C66A, 156.8 ± 6.8 pA/pF, n = 16; compared with CaV2.1[EFb] + vector, 
p = 0.9). Similarly, snapin-C66A also did not affect the current density 
of CaV2.1[EFa] channels (Fig 2.6B and 2.6C). Therefore, snapin 






Figure 2.6 Snapin function as a dimer in modulating calcium channel current.  
A. Snapin but not snapin C66A form dimers as shown under reduced SDS-PAGE 
with addition of 2-Mech. B. left panel, Channel current activated by tail protocol of 
CaV2.1[EFa] with snapin-C66A (blue). Previous results of the CaV2.1[EFa] with (black) 
or without snapin (red) current are shown in dash line. Exemplary traces are shown. 
Right panel, Channel current activated by tail protocol of CaV2.1[EFb] with snapin-
C66A (blue). Previous results of the CaV2.1[EFb] with (black) or without snapin (red) 
current are shown in dash line. Calibration bar: 0.5 nA, 100 ms. C. Summary chart on 
the channel current density. Left panel. Snapin and snapin C66A did not affect 
current of CaV2.1[EFa]. Right panel. Snapin C66A mutation did not increase current 


































































































2.3.4 Snapin did not affect CDF and CDI of CaV2.1 
Reports showed that the proximal C-terminus of VGCC is involved in 
Ca2+-dependent regulation of Ca2+ channels including CDI and/or CDF 
(Chaudhuri et al 2004, Chaudhuri et al 2007, Huang et al 2012, Liang 
et al 2003, Minor & Findeisen 2010). These modulations are highly 
dependent on calmodulin binding to the proximal C-terminus of the 
channel. In order to assess whether the interaction between snapin 
and CaV2.1 affects the Ca2+-dependent modulation by calmodulin, we 
examined the CDI and CDF processes of CaV2.1 channels. The CDF 
of CaV2.1 channels were elicited by a short depolarization followed by 
a pre-pulse. The facilitation was quantified by integrating the difference 
between normalized test-pulse with or without the pre-pulse (∆Q). The 
Relative fraction (RF) is obtained from ∆Q divided by the trace decay 
time (τ). A monotonic RF is expected with Ba2+ as a charge carrier. 
Therefore, CDF was calculated by the difference of RF between Ba2+ 
and Ca2+. As shown in figure 2.7, CaV2.1[EFa] showed robust CDF, but 
snapin did not augment or suppress the facilitation of CaV2.1[EFa] 
channels. In contrast, CDF was essentially non-existent in the 
presence of exon 37b and snapin likewise did not change this outcome 
in CaV2.1[EFb] channels.  
The CaV2.1[EFa] and CaV2.1[EFb] channels usually show robust 
inactivation as recorded within 1 second depolarization. The CDI (f 
value) of the channels was obtained by subtracting the fraction of 




residual amount of current left after 800 ms or 300 ms, r800 and r300, 
snapin did not alter the CDI of CaV2.1[EFa] and CaV2.1[EFb] channels 
(Fig 2.8). As both CDF and CDI of CaV2.1 are highly dependent on 
calmodulin, our results showed that binding with snapin and the 
proximal C-terminus of CaV2.1 did not affect the interaction between 
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Figure 2.7 Snapin did not affect Ca2+-dependent facilitation of CaV2.1.  
The CDF of the CaV2.1[EFa] + vector (n = 9) (A), CaV2.1[EFa] + snapin (n = 10) (B), CaV2.1[EFb] + vector (n = 5) (C) and CaV2.1[EFb] + snapin (n = 7) (D) 
indicated that CDF was unaltered in the presence of snapin. Top CDF was characterized by a rectangular voltage depolarization paradigms. A short test 
pulse depolarization (0 mV, 50 ms) was applied after a pre-pulse (+20 mV). Middle. Exemplary traces of the corresponding evoked Ca2+ currents were shown. 
The test pulse traces showed slow phase activation without a prepulse (grey), while after the pre-pulse, the Ca2+ current was facilitated with a relative fast 
phase of activation. The traces were normalized to unity at the end of the test-pulse. The increased fraction of the area with or without the pre-pulse was 
calculated by relative fraction (RF). Calibration bar represented 0.5 units. Bottom. The RF was represented as a function of pre-pulse voltage obtained in Ba2+  
and Ca2+  solution. Averaged g value was calculated by the difference of RF recorded in Ca2+ and Ba2+  solutions. Mean value of g with +20 mV pre-pulse and 
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Figure 2.8 Snapin did not affect the Ca2+-dependent inactivation of CaV2.1.  
The CDI of CaV2.1[EFa] + vector (A) CaV2.1[EFa] + snapin (B), CaV2.1[EFb] + vector (C) and CaV2.1[EFb] + snapin (D) are shown. Top. CDI was 
characterized by prolonged 1 second depolarization (+10 mV). The CaV2.1 channels produced faster decay of Ca2+ (Grey, filled dot) versus Ba2+ currents 
(Black, open dot). Calibration bar: 0.5 nA. Middle. The averaged inactivation profiles were shown by r800, the remaining fraction of current after 800 ms 
depolarization obtained in Ba2+ and Ca2+, corresponding to a  depolarizing voltage. The CDI is characterized by a f-value representing the difference between 
r800 of Ca2+ and Ba2+. Bottom. The averaged inactivation profiles were also shown by r300. The CDI was characterized based on the inactivation after 300 ms 












Figure 2.9 Alignment of proximal C-terminus of CaV2.1[EFa]/[EFb], CaV2.2[EFa]/[EFb], CaV1.2 and CaV1.3. 
Exon 37 of CaV2.1 and homologous sequences from CaV2.2, CaV1.3 and CaV1.2 were highlighted in grey. The critical differences in amino acids sequences 





2.3.5 Snapin preferentially increased CaV2.2 [EFa] current 
Both CaV2.1 and CaV2.2 are highly expressed in the neurons and 
promote the synaptic transmission (Mochida et al 1996, Wheeler et al 
1994). Similar to CaV2.1, CaV2.2[EFa] and CaV2.2[EFb] are found in 
the nervous system (Bell et al 2004).  It would be interesting to 
evaluate whether snapin could modulate CaV2.2. Therefore, we co-
transfected CaV2.2[EFa] and CaV2.2[EFb] with snapin and examined 
the current density, activation and inactivation potential of CaV2.2 
channels. Surprisingly, we found that snapin preferentially increased 
the current density of CaV2.2[EFa] but not of CaV2.2[EFb] (CaV2.2[EFa] 
+ snapin, 403.7 ± 2.5 pA/pF, n = 12; compared with CaV2.2[EFa] + 
vector, 315.6 ± 2.0 pA/pF, n = 17; p < 0.001). Given that CaV2.2[EFa] 
channels are critical for pain processing, these studies would suggest a 
role for snapin in pain processing. 











315.6 ± 1.9  
(15) 
407.3 ± 2.5 * 
(12) 
169.8 ± 3.0  
(12) 




-2.42 ± 0.45 
(15) 
-0.81 ± 0.40  
(26) 
-0.73 ± 0.35  
(13) 








-25.18 ± 0.70 
(11) 
-23.43 ± 0.62 
(11) 
The number of experiments is indicated in parentheses. V1/2act and V1/2inact represent 
potential of half activation and half inactivation respectively. V1/2act was derived from 
tail-activation curves recorder in Ba2+ solution and V1/2inact was derived from SSI 
recorded Ba2+ solution (Fig. 2.10). For statistics, * p < 0.001, compared with same 








Figure 2.10. Modulation on CaV2.2 current by snapin. 
 A. Channel current activated by tail protocol of CaV2.2[EFa], CaV2.2[EFb] with (red) 
or without snapin (black). Upper panel, exemplary traces of the tail current activated 
at -20 mV, +10 mV and +50 mV. Calibration bar: 1 nA, 10 ms. B. Activation and 
inactivation curves were obtained from a tail protocol and steady-state inactivation 
protocol. The two curves of CaV2.2[EFa], CaV2.2[EFb] and CaV2.1[EFb,47+] with (red) 
or without snapin (black) were plotted in the same chart. Upper panel, exemplary 
traces of the stead-state inactivation of normalization pulse and test pulse. Calibration 
bar: 0.5 nA, 100 ms. * p < 0.001. Each group was compared with and without snapin 
by Student t-test. 
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Figure 2.11 Primary hippocampal neuronal culture.  
A. 5 days after plating (DIV 5). The dendrites started to grow and many branches 
could be observed. The axon extended over hundreds of micro-meters and beyond 
the field of view. B. 10 days after plating (DIV 10). Extensive connections had been 
formed with the nearby neurons.  C. 16 days after plating (DIV16). The neuron bodies 












2.3.6 Snapin and synaptic transmission 
Our studies has revealed that snapin preferentially increased the 
current density of two splice variants CaV2.1[EFb] and CaV2.2[EFa]. 
Given the crucial role of CaV2.1 in synaptic transmission, it would be 
interesting to access whether snapin affects synaptic transmission 
through interacting with CaV2.1 channel. Previous works has shown 
that snapin-deficient neurons did not respond to high-frequency 
stimulus and synchronizing release was abolished (Pan et al 2009). 
We prepared primary hippocampal neurons culture according to 
Banker’s protocol. The hippocampal neurons in various stages of 
culture were shown in figure 2.11 and 2.12. Snapin is highly expressed 
in the synapses and co-localized with synapsin, markers of the 
presynaptic terminals (Fig. 2.13).  
In order to examine how snapin affects synaptic transmission, we used 
shRNA to knockdown snapin expression in the cultured neurons. Two 
shRNAs targeting the coding sequences of snapin were used in this 
study. We packaged the shRNA in lentivirus and infected the primary 
neurons at DIV8 and our results showed that the expression of snapin 
was suppressed as shown in figure 2.14A. 
To examine the functional effects of snapin knockdown, we have 
recorded the spontaneous EPSC in the cultured neuron by whole-cell 
patch clamp electrophysiology (Fig. 2.14). Our results indicated that the 
amplitude of sEPSC was not affected. Taken together our results 




localized with synapse marker, synapsin and knocking down snapin did 




Figure 2.12 The dendrites and synapses are visualized with MAP2 and synapsin 
antibodies. 
The 16-day-old culture was fixed in paraformaldehyde and immunostained with anti-
MAP2 and anti-synapsin antibodies. MAP2 decorate the dendritic microtubules and 







Figure 2.13 Double labeling of snapin (red) and synaptic marker synapsin (green) in 
primary hippocampal neuron.  
A. The primary hippocampal neuron cultures were fixed at DIV 16. Positive 
immunocytochemical staining for presynaptic marker. Synapsin is labeled in green 
and snapin is labeled by red. DAPI (blue) stains the nuclears of neurons. Scale bar, 
20 μm. B. The magnfied photos showed that snapin and synapsin are co-localized in 












Figure 2.14 Snapin did not affect the spontaneous vesicle release 
A. RT-PCR showed expression snapin was reduced by shRNA in neurons. B. 
Exemplary traces by spontaneous EPSC. C.D.  Knockdown snapin did not affect the 












2.4 Discussion  
2.4.1 Diversified function of CaV2.1[EFa] and CaV2.1[EFb] variants 
In these studies, we have examined the interaction between snapin 
and CaV2 channels. We found that snapin could preferentially modulate 
CaV2.1 channels containing either exon 37 splice variant. The 
CaV2.1[EFa] and CaV2.1[EFb] are mutually exclusive splice variants. 
Using yeast-two-hybrid and GST pull-down assays, we have shown 
that snapin preferentially bound to the N-terminal region of exon 37b. 
The interaction between snapin and CaV2.1 increases CaV2.1[EFb] but 
not CaV2.1[EFa] current density. Alanine substitutions of CaV2.1 exon 
37b disrupted the interaction between snapin and calcium channels. 
Given the important role CaV2.1 channels play in triggering synaptic 
vesicle release, the amount of Ca2+ influx through the channels will 
affect synaptic transmission (Catterall & Few 2008). Our studies 
provide a new insight into the diversified functions of CaV2.1[EFa] and 
CaV2.1[EFb] variants. Alternative splicing events usually occur in 
tissues and cells with complex functions (Modrek et al 2001, Yeo et al 
2005). Mutually exclusive splicing of exon 37 occurs in two similar 
VGCCs, CaV2.1 and CaV2.2, and they are found in most mammals. 
The CaV2.1[EFa] and CaV2.1[EFb] have been shown to display subtle 
differences in electrophysiological properties such as current density 
and CDF (Bourinet et al 1999, Chaudhuri et al 2004, Chaudhuri et al 
2007, Soong et al 2002). The preferential binding of snapin with 




CaV2.1[EFb] functions in triggering synaptic transmission and synaptic 
plasticity. As suggested by previous studies in our laboratory, the 
expression of CaV2.1[EFa] and CaV2.1[EFb] is under spatial and 
temporal regulations. There are predominant EFb variants in early 
brain development and after the first two decades of life, there would 
be about equal expression levels of CaV2.1[EFa] and CaV2.1[EFb] 
(Chang et al 2007). Although the mechanisms underlying the 
developmentally regulated expression regulation is unknown, our 
results may help to explain the distinct roles of CaV2.1[EFb] in early 
development. 
2.4.2 Interaction between snapin and CaV2.1 potentiates 
synchronous vesicle release 
Snapin is crucial for synchronous vesicle release as snapin-deficient 
neurons could not respond to high-frequency input precisely and 
effectively during synaptic transmission (Pan et al 2009). Synchronous 
release is supported by large and localized Ca2+ influx through VGCCs 
at the active zone (Martens et al 2007). It requires close alignment of 
Syt-1, SNARE and Ca2+ channels. Our results revealed that snapin 
binds to CaV2.1 channels and promotes Ca2+ influx through VGCCs. 
Two possible mechanisms may explain the role of snapin binding to 
CaV2 in synchronous release: (1) Snapin facilitates Ca2+ influx and 
simply increases local Ca2+ concentration. Elevated transient [Ca2+] 
leads to more stable Syt I-Ca2+ and Ca2+-triggered Syt-I will switch 




interaction with the SNARE complex. Therefore, the higher the local 
Ca2+ concentration, the more efficient it is to trigger synchronous 
vesicle release; (2) Snapin has been shown to bind to Syt-I, SNAP-25 
and VGCC. These multiple protein interactions may form a complicated 
complex with VGCC-SNARE-Syt-I-snapin. Syt I-Ca2+ fused with 
SNARE during Ca2+ influx (Zhang et al 2002a) and snapin could 
stabilize the Syt-I-SNARE complex before Ca2+ influx (Pan et al 2009, 
Tian et al 2005). The close distance between VGCCs and Syt-I-
SNARE complex would be coupled to Ca2+ influx and the vesicle fusion 
process better and then lead to efficient synchronous release. 
Studies from our group have shown that pre-synaptically expressed 
CaV2.1[EFa] and CaV2.1[EFb] would differentially affect plasticity of 
transmitter release upon paired stimulations in cultured neurons. The 
CaV2.1[EFa] channels triggered a large initial EPSCs and small EPSC 
in the following stimulus. While the CaV2.1[EFb] channels mediated an 
augmented post-synaptic current upon paired-pulse stimulus (Ng et al 
unpublished). The repetitive Ca2+ influx strengthened the connection 
between Syt-I-SNARE complex and VGCC and resulted in increasing 
post-synaptic currents. However, without the interaction between 
snapin and VGCC, the vesicles are likely to be depleted, resulting in 




2.4.3 Snapin preferentially recruited EF-hand splice variant of 
Ca2+ channels to the active zones of presynaptic terminals 
The active slot for VGCC in mediating synchronous vesicle release is 
limited. Both CaV2.1 and CaV2.2 channels are competing for the active 
zone of the presynaptic sites (Cao & Tsien 2005, Cao & Tsien 2010). 
Several proteins such as RIM, Rab3 and Munc 13 have been shown to 
anchor the CaV2.1 and CaV2.2 channels to the active slots (Deng et al 
2011, Han et al 2011, Kaeser et al 2011). It has been reported that 
bassoon selectively controlled CaV2.1 but not CaV2.2 recruitment to 
active zone (Davydova et al 2014). Furthermore, snapin is also 
reported in SNARE protein retrograde transportation. Deficient snain-
dynein interaction impair the autophagic vesicle transportation, which 
cause vesicle aggregations in synaptic terminals (Cheng et al 2015) 
The preferential binding of snapin to CaV2.1[EFb] and CaV2.2[EFa] 
may be involved in selective recruitment of the splice variants to 
presynaptic active zones. Snapin has been shown to be involved in 
retrograde protein trafficking through interacting with dynein (Cai et al 
2010). Studies showed that snapin modulate the transportation of 
several membrane proteins to cell membrane including TRPM7, BDNF-
TrkB and TMPAP, etc. (Krapivinsky et al 2006, Quintero et al 2013, 
Zhou et al 2012). The availability of VGCC in the presynaptic zone 




2.4.4 Exon 37 is crucial for EF-hand like domain structure and 
channel function 
In our studies, we have tried to mutate several amino acids in the EF-
hand like domain and examined the functional effects of CaV2.1-snapin 
interaction. However, several mutant full-length channels including 
MPL-triple mutations, W-A, M-A, P-A single mutation, could not 
conduct Ca2+ currents. It has been reported that the truncated VGCC 
without the EF-hand like domain is non-functional (Graves et al 2008). 
The alanine substitution in the CaV2.1 exon 37b mutant may be 
structurally altered and the net result is channel dysfunction (Peterson 
et al 2000). 
2.4.5 Snapin modulated CaV2.2[EFa] and potential implication in 
pain processing 
In addition to CaV2.1, our results also showed that snapin preferentially 
increase the current density of CaV2.2[EFa] but not CaV2.2[EFb]. The 
CaV2.2 channels have been shown to be involved in the pain 
processing. In particular, CaV2.2[EFa] is more efficient in transmitting 
pain signals than CaV2.2[EFb] because it is exclusively expressed in 
small nociceptive neurons and it conducts larger currents. The 
preferential effects of snapin may facilitate the pain processing 
mediated by CaV2.2[EFa] and disruption of the interaction between 




2.4.6 EF-hand and calmodulin 
The EF-hand domain of CaV2.1 resembles the similar domain in the 
proximal C-terminus structures in NaV channels (Chagot et al 2009). 
The atomic structure of one helical part of EF-hand and the 
downstream pre-IQ and IQ domain has been resolved in the 
homologous CaV1.2 segment. Recent studies have proposed the 
possible role of EF-hand domain in interacting with apoCaM, the 
calcium freeform of calmodulin. Mutations on the conserved region of 
exon 37 in CaV1.3 attenuate CDI formation. It is suggested that the 
CaM is pre-associated with EF-hand and IQ domain. Upon Ca2+ influx, 
CaM was trans-located and lead to calcium dependent inactivation. 
Our studies revealed a novel function of EF-hand in interacting snapin. 
In additional to the augment on CaV2.1 current, snapin did not affect 
the CDF and CDI of Cav2.1[EFa] or Cav2.1[EFb]. Therefore, snapin-
CaV2.1 interaction does not affect the calmodulin function. These 
results could be explained that calmodulin has high affinities to CaV2.1 
upon Ca2+ influx. It would replace snapin in interacting with the EF-
hand. Therefore, the calmodulin interaction between snapin and Cav2.1 
seems not affected.  
Snapin usually forms a dimer with disulfide bond. The snapin dimmer 
interact with the synaptagmin-1 and snapin monomer, snapin-C66A 
could not rescue the deficiency of synchronous release in snapin 
knockout neurons. We find that snapin also interact with CaV2.1 with 




current density, suggesting the widely appearance of snapin 
dimerization in synaptic function. 
2.4.7 Snapin and synaptic transmission 
In these studies, we have tried to knock down snapin and examined 
the synaptic transmission. We knock down the snapin by transfect the 
shRNA in neurons using lentivirus. It is shown that the expression of 
snapin was partially inhibited in the neurons with shRNA. In profiling 
the synaptic transmission, we found that the spontaneous activities of 
synaptic transmission were not much affected with snapin knocking 
down. The amplitudes of sEPSC represented the amount of 
asynchronous vesicle release. Paired stimulus would be considered in 
future studies to identify the synchronous vesicle release. Therefore, a 
single neuron would be depolarized and activate the nearby neuron 
transmitter release.  
2.4.8 Conclusion and future studies 
Our studies here revealed a novel interaction between the snapin and 
C-terminus of CaV2.1. Striking, these interactions were preferentially to 
CaV2.1[EFb] splice variant instead of CaV2.1[EFa]. The N-terminals of 
exon 37b were crucial for the binding with snapin. Functionally, snapin 
selectively increased the current density of CaV2.1[EFb] compared to 
CaV2.1[EFa]. Mutation on the N-terminals of exon 37b disrupt the 
interaction between snapin and CaV2.1[EFb]. Moreover, the snapin 




Substituting the cysteine 66 to alanine of snapin disrupted snapin-
CaV2.1 interaction.  
CaV2.1 mediates the Ca2+ influx and play a crucial role in triggering 
vesicle release. Given the crucial role of snapin in interacting several 
proteins related to vesicle release, including SNAP-25 and Syt-I 
(Chheda et al 2001, Ilardi et al 1999, Pan et al 2009), would the 
interaction between snapin and CaV2.1 affect the synaptic release?  
Previous studies have identified the interaction between synprint region 
VGCC and syntaxin and Syt-I (Bezprozvanny et al 1995, Rettig et al 
1996, Simms & Zamponi 2014, Weiss & Zamponi 2012). It is not clear 
that how does snapin-CaV2.1 interaction affect the relationships 
between VGCC and SNARE complex. Does snapin compete for VGCC 
binding to syntaxin and Syt-I or facilitate the multiple protein interaction 
in complicated protein complex? We would knockdown snapin or 
overexpress the dominant-negative mutation snapin C66A in neurons 
and use immunoprecipation assay to pull down the presynaptic 
complex. These studies may further elucidate the role of snapin in 
presynaptic vesicle release machinery.  
The preliminary studies have been performed by knocking down snapin 
in primary neuron. Although the synaptic transmission of snapin 
deficient neuron has been characterized, the dysfunction of retrograde 
transportation and altered development may induce wide-ranging effect 
on neuron (Cai et al 2010, Pan et al 2009, Tian et al 2005). Therefore, 




shown that synchronized release of synaptic transmission is altered in 
snapin deficient neurons (Pan et al 2009). In the future studies, we will 
examine the synaptic transmission under high frequency stimulation 
and whether the synaptic transmission is altered in snapin knockdown 
neurons. In addition, since the CaV2.1[EFa] and CaV2.1[EFb] display 
distinct roles in short-term synaptic plasticity, whether the preferential 
interaction of snapin on CaV2.1[EFb] would affect the short-term 
synaptic plasticity. Therefore we would deliver paired stimulus on 
culture neurons. Two interconnected neuron would be patched at the 
same time. The depolarization on one neuron would induce post-
synaptic current in the other neuron through synapse. We would knock 
down snapin in one neuron and examine the synaptic current in the 
other. The fluorescence marker carried by snapin shRNA would help to 
identify the transfected neuron. It would helpful to explain how snapin 
affect the synaptic transmission. 
Furthermore, we would examine the synaptic vesicle release using 
VGlut1-pHluorin (Burrone et al 2007). The pH sensitive protein VGlut1-
pHluorin displays fluorescence green when it is released from the 
vesicles to synaptic clefts. The amount of fluorescence represents he 
amount of vesicle release. We would use this methology to examine 






Chapter 3  Splice-variant-selective 





CaV1.3 is one of the L-type voltage-gated calcium channels and it is 
widely expressed in excitable cells. These channels are highly enriched 
in the superchrismatic nucleus and substantia nigra of brain, sinoatrial 
nodes of heart and inner hair cells (IHCs) of cochlea (Brandt et al 2005, 
Platzer et al 2000, Zhang et al 2002b). Although the sequence is quite 
similar to CaV1.2, CaV1.3 channels display several unique features. 
The CaV1.3 channel is characterized by its low activation threshold, 
independent of the tissue of origin or the auxiliary subunits associated 
with it. It is usually activated from -45 mV to -60 mV (Xu & Lipscombe 
2001). In addition, CaV1.3 channels are less sensitive to 
dihydropyridine antagonists as compared to CaV1.2 (Huang et al 2013). 
The CaV1.3 gene can be extensively modified post-transcriptionally. In 
addition to extensive alternative splicing (Shen et al 2006, Tan et al 
2011), CaV1.3 pre-mRNA could be edited by adenosine deaminase, 
in the IQ-domain to affect Ca2+-dependent inactivation (Huang et al 
2012, Adams et al 2014).  
3.1.1 CaV1.3 in cochlea during development  
Calcium currents in cochlea were first described in the chicken hair 
cells. Whole-cell patch clamp studies in hair cell have recorded voltage 
sensitive Ca2+ currents (Fuchs & Sokolowski 1990). Unlike other 
synapses in the nervous system, Ca2+ channels in the inner hair cells 
are exclusively CaV1.3 instead of CaV2.1 or CaV2.2 (Kollmar et al 




a reduction of over 90% of the Ca2+ currents in the inner hair cells 
(Platzer et al 2000). It is known that CaV1.3 channels play a critical role 
in inner hair cells during different developmental stages. Prior to 
hearing onset, CaV1.3 is essential for cochlea development. CaV1.3 
mediates spontaneous action potential in rodent immature inner hair 
cells. These spontaneous activity is essential for synapse formation 
and wiring of the neuronal network in the cochlea (Kros et al 1998). It 
has been shown that CaV1.3 channels in immature neurons exhibit 
larger Ca2+ currents and stronger voltage-dependent inactivation than 
that found in mature neurons, which may shape the activation potential 
waveforms (Inagaki & Lee 2013). Moreover, CaV1.3 channels in the 
immature inner hair cells are rarely associated with synaptic vesicles in 
the ribbon synapse (Zampini et al 2010). In adult IHCs, CaV1.3 senses 
graded voltage depolarization from hair bundle vibration and Ca2+ influx 
through CaV1.3 would eventually trigger vesicle release (Fuchs 2005, 
Song et al 2003). 
3.1.2 I-II loop region of CaV1.3 
The I-II loop contains the β-subunit binding domain. It is crucial for 
calcium channel trafficking and protein ubquitination (Altier et al 2011). 
Several splice sites in the I-II loop have been identified. It was reported 
that alternative exon 9* and exon 11 of CaV1.3 are located at the I-II 
loop (Kollmar et al 1997a, Kollmar et al 1997b). The alternative splicing 
of a paralogous exon 9* could also be found in the CaV1.2 channels 




intracellular I-II loop region may obstruct the calcium channel pore and 
alter its biophysical properties. The inclusion of additional amino acids 
through the inclusion of exon 9* may therefore alter the topology of the 
β-subunit binding region. Exon 11 is unique to CaV1.3 and the 
homologous sequences of exon 11 are not found in CaV1.2 or other L-
type calcium channels. Exon 11 contains 20 amino acids, which is a 
slightly shorter than exon 9*. The inclusion of exon 11 could be found 
in brain, heart and cochlea, though the functional studies on CaV1.3 
channels containing exon 11 is limited. 
3.1.3 CaV1.3 undergoes feedback modulations 
For its vital role in cellular function, CaV1.3 is subject to negative 
feedback regulation by a rise in internal Ca2+ concentration (Calcium-
dependent inactivation, CDI) and by membrane voltage change 
(Voltage-dependent inactivation, VDI). These feedback regulations are 
modulated with post-transcriptional modification on CaV1.3 (e.g. 
alternative splicing and RNA editing). Similar to CaV2 family, Ca2+- 
dependent inactivation of CaV1.3 channels is achieved by Ca2+-
calmodulin binding to the C-terminus of the CaV1.3 channels (Adams et 
al 2014, Peterson et al 1999, Zuhlke et al 1999). Studies from Huang et 
al have shown that post-transcriptional modification by RNA editing 
could convert the isoleucine (I) to methionine (M), and glutamine (Q) to 
arginine (R). The edited channel has significantly reduced CDI as 
compared to the un-edited channel (Ben Johny et al 2013, Huang et al 




determined by alternative splicing. Some splice variants found in the 
cochlea were truncated in the proximal C-terminals without the IQ-
domain. The CDI of the truncated CaV1.3IQ was abolished due to the 
absence of the IQ-domain (Shen et al 2006). In addition, alternative 
splicing of the CaV1.3 on the distal C-terminus also affected the 
strength of CDI. The CaV1.3 is mutually exclusive spliced by exon 42 
and exon 42a. Exon 42a would generate a premature stop codon 
immediately after the IQ-domain. The CaV1.342a is called the short-form 
or CaV1.342a compared to the long-form CaV1.342 (CaV1.3 long form). 
The long-form of CaV1.3 expresses weak CDI as compared to 
CaV1.342a channels. It is shown that the distal C-terminus of CaV1.3 
long form contains a CDI inhibiting domain and may occlude the 
calmodulin-binding domain and diminished the CDI (Liu et al 2010). 
The VDI process is initiated by a conformation change of the S1-S4 
segment in response to voltage depolarization. The subsequent 
movements of S6 segment and I-II loop block the gating pore of the 
calcium channel by a possible “hinge-lid” mechanism (Tadross & Yue 
2010). Recent studies found that the S6 in CaV1.3 repelled the lid 
closure, which keep the channel open despite the long time voltage 
depolarization (Tadross et al 2010). The VDI and CDI avoid excessive 
Ca2+ influx through VGCC. Mutation on the S6 segment of CaV1.2 
cause delayed VDI and the excessive Ca2+ influx leads to heart failure 
in Timothy syndrome patients (Splawski et al 1993, Splawski et al 




3.1.4 Objectives and rationale 
The previous works have shown that snapin preferentially increases 
the current density of the splice variants such as CaV2.1[EFb] and 
CaV2.2[EFa]. The interaction between snapin and calcium channel may 
increase the efficiency of synaptic transmission. CaV1.3 triggers the 
vesicle release in ribbon synapse of inner hair cell. In this study, we 
would like to examine whether snapin also modulates CaV1.3 in a 
similar fashion as for CaV2.1 or CaV2.2 channels. Here, we have 
examined the effects of snapin on three neuronal types of CaV1 
families: CaV1.2, CaV1.3 and CaV1.4 channels.  
In addition, CaV1.3 can undergo extensive alternative splicing and the 
splicing pattern could potential change in various developmental 
stages. We further examined the splicing pattern of CaV1.3 in the 






3.2 Materials and methods 
3.2.1 Materials 
Experiments were carried out on Sprague-Dawley rats with 8 to 9 
weeks old, as approved by the NUS IACUC. The full-length human 
CaV1.2, CaV1.3, CaV1.4 subunits were reported in previous studies 
(Huang et al 2012, Tan et al 2011, Tan et al 2012, Wang et al 2011).  
3.2.2 Construction on the GST-fusion protein  
The GST-fusion protein with CaV1.3 fragments was generated as 
previously described. The I-II loop, I-III-loop, III-IV loop and C-terminus 













The CaV1.3∆E11 was given by Huang Hua. The I-II ∆E11 amplified using 
the primers of 1.3LF-I-II-Fw and 1.3LF-I-II-Re. The PCR products were 
cloned into pGEX4T-1 as previously described in chapter 2.  
3.2.3 Western blot and co-immunoprecipation 
The GST-pull down assay was performed similarly as chapter 2, using 
glutathione sepharose beads (GE Health). Immunoprecipation was 
performed to examine the interaction between snapin and full-length 
CaV1.3. HEK cell lysis transfected with CaV1.3 and snapin were mixed 
with 1 μg of anti-CaV1.3 primary antibodies (Alomone AC-005) and 
incubated overnight at 4°C. Then the mixture was incubated with 15 μl 
of Protein A-Sepharose for 3 hr at 4°C. The beads were washed with 
PBS for three times and the immunoprecipitated protein were detected 
with SDS-PAGE and immunoblotting. Rabbit anti-CaV1.3 (1:200) and 
rabbit anti-snapin (SYSY, 1:1000) were used for blotting.  
3.2.4 Total RNA extraction for cochlea 
The cochleas from rats were rapidly dissected after decapitation. Total 
RNA of tissue was isolated using the Trizol (Life Technologies, CA). 
First strand cDNA was synthesized with Superscript III (Life 




according to manufactory instructions. 
Rat ex7-17 Re CCAGTCTGGCTGATTGTAGTGCTC 
RNA minus control reactions without adding reverse transcriptase were 
performed in all RT-PCR experiments to exclude genomic DNA 
contamination.  
Subsequent PCR was performed using following primers. 
Rat ex7-17 Fw CTTTGCCATGCTCACTGTGT 
Rat ex7-17 Re CCAGTCTGGCTGATTGTAGTGCTC 
3.2.5 Colony screen for the alternative splicing 
Colony screening was performed to determine the splicing ratio of 
particular splicing sites. The PCR products of I-II loop of CaV1.3 from 
cochlea RNA were sub-cloned into pGEM-T easy vector (Promega, 
WI). The ligation products were then transformed to DH10B E. coli 
competent cell with electronic shock and spread into LB-plate. Isolated 
clones were picked from LB-plate and colony PCR was performed 
using  
Rat ex9-14 Fw ACCTGGTTCTTGGTGTCCTTAGTG 
Rat ex9-14 Re CCAGTCTGGCTGATTGTAGTGCTC 
The splicing patterns were determined by the DNA size and the 




3.2.6 Mammalian cell culture and transfection 
HEK293 cells were maintained as previous described (2.3.2). CaV1.3 
channels and snapin was transfected in to HEK cells by calcium 
phosphate transfection. The DNA plasmids, pIRES-DsRed-Snapin / 
pIRES-DsRed (1 μg), CaV1.3 (1.7 μg), β2a (1.25 μg) and α2δ1 (1.25 μg) 
as well as T-antigen (0.25 μg) were used for 35 mm dishes. For 
biochemical studies, the HEK cell were transfected using 
lipofectamine™ 2000 according to the standard procesures (Life 
Technologies, CA). 
3.2.7 Whole cell patch clamp electrophysiology 
The whole cell patch clamp on the HEK cell was performed as 
described. The external solution contained (in mM) 10 HEPES, 140 
TEA-MeSO3 5 CaCl2 or 5 BaCl2 (pH 7.4, Osmolarity 300-310 mOsm). 
The glass pipettes were back- filled with pipette solution contained  (in 
mM) 10 HEPES, 5 CsCl, 138 Cs-MeSO3, 5 EGTA, 1 MgCl2, 2 mg/ml 
MgATP, (pH 7.3 Osmolarity 290-300 mOsm).  
In these studies, Tail, SSI and CDI/VDI were performed to examine the 
channel properties. The programs and analysis were same as in 
chapter 2. All data were represented with Mean ± SEM and compared 





3.3.1 Snapin bound to I-II loop of CaV1.3 and increases CaV1.3 
current density 
Our previous work showed that snapin preferentially increased 
CaV2.1[EFb] and CaV2.2[EFa] currents (Fig. 2.4 and Fig. 2.10). These 
two channels from CaV2 family are responsible for triggering vesicle 
release in the central neurons. Other than CaV2.1 and CaV2.2, CaV1.3 
is expressed in the cochlear inner hear cells and influx of Ca2+ through 
these channels triggers vesicle release in ribbon synapse (Fuchs 2005, 
Platzer et al 2000). Therefore, we would like to examine whether 
snapin, which is found in the presynaptic terminal, could potentially 
interact with CaV1.3 channels. To investigate the electrophysiological 
properties of snapin-CaV1.3 interaction, we co-expressed CaV1.3 with 
snapin in HEK 293 cells and recorded the current density and 
activation/inactivation potentials of CaV1.3 channels by the standard tail 
and steady-state inactivation protocols. As shown in figure 3.1, snapin 
increased the current density of CaV1.3 by 30% using Ba2+ as the 
charge carrier (CaV1.3 + vector, 102.8 ± 3.4 pA/pF, n = 24; CaV1.3 + 
snapin, 131.9 ± 5.1 pA/pF, n = 19; p < 0.001). Furthermore, Snapin 
modestly shifted the V1/2act of activation curve of CaV1.3 to the left 
(V1/2act: CaV1.3 + vector, -18.75 ± 0.70 mV, n = 18; CaV1.3 + snapin, -






Figure 3.1 Snapin preferentially modulated CaV1.3 but not CaV1.3∆E11. 
A.B. Channel current density of CaV1.3 recorded by tail protocol (A) and CaV1.3∆E11 
(B) with (red) or without snapin (black). Upper panel, exemplary traces of the tail 
current activated at -20 mV, +10 mV and +50 mV. Calibration bar: 1 nA, 10 ms. C.D. 
Activation curve and inactivation curve were obtained from tail and steady-state 
inactivation protocols. The two curves of CaV1.3 (C) and CaV1.3∆E11 (D) with (red) or 
without snapin (black) were plotted in the same chart. Upper panel, exemplary traces 
of the steady-state inactivation of normalization pulse and test pulse. Calibration bar: 
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Figure 3.2 Snapin preferentially bound to CaV1.3 I-II loop containing exon 11. 
A. Schematic diagrams of CaV1.3. Several cytosolic regions of CaV1.3 were labeled 
in red. Exon 11 is alternatively spliced in the CaV1.3 I-II loop. B. GST fusion protein of 
I-II loop, I-II loo ∆E11, II-III loop, III-IV loop, EF-hand and 42a short form C-terminus 
were generated by cloning the respective regions of CaV1.3 into pGEX4T1 vector. C. 
Coomassie blue staining showed the purified GST-fusion proteins. D. GST-pull down 
assay was performed by incubating the GST-fusion protein beads with cell lysates of 
HEK 293 cells transfected with snapin. I-II loop of CaV1.3 pulled down selectively 







Figure 3.3 Snapin preferentially bound to full-length CaV1.3 containing exon 11. 
Co-IP assay was performed using anti-CaV1.3 antibody. Full-length CaV1.342a, 
CaV1.342, and CaV1.342∆E11 were used to pull-down snapin. Snapin could be bound to 







In order to discover the potential binding regions within CaV1.3 for 
snapin, we screened the cytosolic loop regions of CaV1.3, including I-II 
loop, II-III loop, III-IV loop, EF-hand like domain and C-terminus. We 
cloned the cytosolic parts of CaV1.3 into GST-expression vector (Fig. 
3.2A and 3.2B). Unexpectedly, using GST-fusion protein to pull down 
the cell lysates with snapin, we found that snapin did not interact with 
the EF-hand like domain in stark contrast to the results obtained for 
CaV2.1 channels. However, the results of the pull-down assays indicate 
that the I-II loop of CaV1.3 contained the critical binding site (Fig. 3.2D). 
Therefore, we may have uncovered a novel interaction between snapin 
and CaV1.3 in the I-II loop.   
The CaV1.3 I-II loop could be alternatively spliced at exon 9* and exon 
11 (Xu & Lipscombe 2001). The reference clone used in our 
experiments contained ∆9*/E11, which is the most common splice 
variant in the nervous system. In order to determine whether the 
inclusion or exclusion of exon 11 affects snapin binding to CaV1.3, we 
have assessed the biochemical interactions between snapin and I-II 
loop lacking exon 11, as well as perform electrophysiological 
investigations of CaV1.3∆E11 channels. We generated the GST-fusion 
protein of I-II loop (∆E11) and our results by GST pull-down assays 
showed that I-II loop (∆E11) did not pull down snapin (Fig. 3.2D). 
Moreover, we have performed immunoprecipitation using anti-CaV1.3 
antibody and found that both the long-form and short-form of CaV1.3 
could pull down snapin. By contrast, CaV1.3∆E11 did not pull down 




crucial for snapin-CaV1.3 interactions. In addition to the biochemical 
studies, we examined the electrophysiological properties of CaV1.3∆E11 
channels. Figure 3.1B showed that snapin did not increase the Ca2+ 
current density (CaV1.3∆E11 + vector, 110.7 ± 2.0 pA/pF, n = 13; CaV1.3
ΔE11 + snapin, 116.9 ± 5.1 pA/pF, n = 16; p = 0.31), suggesting that 
exclusion of exon 11 abolished the effect of increased current due to 
binding of snapin. In comparing voltage sensing, snapin could still 
slightly shifted the V1/2act of CaV1.3∆E11 to the hyper-polarized direction, 
as compared with the same channel without snapin (V1/2act: CaV1.3∆E11 
+ vector, -14.89 ± 0.96 mV, n = 23; CaV1.3∆E11 + snapin, -17.92 ± 0.81 
mV, n = 23; p = 0.020).  
In short, our results discovered a novel interaction between CaV1.3 I-II 
loop and snapin. Snapin-CaV1.3 interaction increased the CaV1.3 
current by 30%. These interactions were dependent on the presence of 
alternative exon 11. Moreover, snapin slightly shifted the activation 
potential to the hyperpolarized direction of both CaV1.3 and CaV1.3∆E11 
channels. In addition, our electrophysiological data also showed that 
inclusion of exon 11 shifted the V1/2act of CaV1.3 slightly to left by 4 mV 
(Table 3.1, p < 0.001). These results suggested that the exon 11 

















102.8 ± 3.4 
(24) 
131.9 ± 5.1* 
(19) 
110.7 ± 2.0 
(13) 
116.9 ± 5.1 
(16) 
V1/2act (mV) 
-18.75 ± 0.70 
(23) 
-22.27 ± 0.70* 
(26) 
-14.89 ± 0.96# 
(18) 
-17.92 ± 0.81 
(16) 
V1/2inact (mV) 
-42.37 ± 1.19 
(11) 
-39.06 ± 1.67* 
(9) 
-43.34 ± 0.70 
(8) 
-41.74 ± 1.30 
(7) 









310.7 ± 17.4 
(20) 
294.0 ± 16.8 
(14) 
22.60 ± 1.26 
(11) 
24.21 ± 1.08 
(15) 
V1/2act (mV) 
-4.67 ± 0.79 
(17) 
-4.56 ± 0.86 
(20) 
-3.76 ± 0.69 
(10) 
-3.40 ± 1.11 
(12) 
V1/2inact (mV) 
-30.56 ± 0.59 
(11) 
-33.90 ± 0.33* 
(11) 
-38.07 ± 2.89 
(7) 
-40.73 ± 2.52 
(10) 
The number of experiments done is indicated in parentheses. V1/2act and V1/2inact 
represent potential of half activation of half inactivation. V1/2act was derived from tail-
activation curves recorded in Ba2+ (Figure 3.1C and 3.4C) and V1/2inact was derived 
from steady-state inactivation curve recorded Ba2+ (Figure 3.1D and 3.4D), *p < 0.001, 
compared with or without snapin, #p < 0.001, compared between CaV1.3 and 





3.3.2 Snapin did not affect CaV1.2 and CaV1.4 properties  
The alternative exon 11 is distinct to CaV1.3 and there is no paralogous 
sequence of exon 11 in CaV1.2 and CaV1.4 channels. In order to 
determine whether snapin preferentially modulates CaV1.3 but not 
other L-type channels, we have examined snapin effect on the other 
two neuronal CaV1 channels: CaV1.2 and CaV1.4. Therefore, we co-
expressed snapin and CaV1.2 or CaV1.4 channels in the HEK 293 cells 
and the results showed that snapin did not significantly affect the 
current densities of CaV1.2 and CaV1.4 channels (Fig 3.4A, 3.4B and 
Table 3.1). To compare voltage sensing of CaV1.2 and CaV1.4 
channels, we recorded and analyzed the V1/2act and V1/2inact by tail and 
steady-state inactivation protocols. The inactivation of CaV1.2 was 
slightly hyperpolarized shifted by snapin by 3 mV (Fig 3.4 and Table 
3.1). Taken together, among the three neuronal L-type calcium 
channels, snapin preferentially interacted with CaV1.3 and snapin binds 
to CaV1.3 in the presence of alternative exon 11. The novel interaction 
mechanism between snapin and CaV1.3 increased the channel 






Figure 3.4 Snapin did not alter channel properties of CaV1.2 and CaV1.4 channels 
A. Channel current density of CaV1.2 recorded by tail protocol with (red) or without 
snapin (black). Upper panel, exemplary traces of the tail currents activated at -20 mV, 
+10 mV and +50 mV. Calibration bar: 0.5 nA, 10 ms. B.  Channel current density of 
CaV1.4 recorded by tail protocol with (red) or without snapin (black). Upper panel, 
exemplary traces of the tail current. Calibration bar: 100 pA, 10 ms. C. Activation 
curve and inactivation curve were obtained from a tail protocol and steady-state 
inactivation protocol. The two curves of CaV1.2 with (red) or without snapin (black) 
were plotted in the same chart. Upper panel, exemplary traces of the steady-state 
inactivation of normalization pulse and test pulse. D. Activation curve and inactivation 
curve of CaV1.4 were similarly plotted. Calibration bar: 50 pA, 100 ms. Each group 






















































3.3.3 Snapin modulated the CaV1.3 VDI 
The CaV1.3 I-II loop has been shown to be involved in voltage-
dependent inactivation. The I-II loop blocks the gating pore of channel 
after voltage depolarization. The inclusion of exon 11 extended the I-II 
loop length and it is not clear whether exon 11 is involved in voltage-
dependent activation. We recorded the VDI by holding the membrane 
potential with depolarized voltages for 500 ms. The inactivation ratio 
was determined by the remaining current after 300 ms divided by peak 
current. Although snapin did not affect the r300 obtained at the peak 
value stimulus (-10 mV), it could modestly reduce the VDI at -40 mV 
(Fig. 3.5, Table 3.2. p = 0.032). By comparing the r300 along with the 
depolarizing voltage, snapin inhibited the VDI in hyperpolarized voltage 
but snapin slightly facilitated the VDI in more depolarized voltages. 
These results suggested that snapin binding to I-II loop of CaV1.3 might 






Figure 3.5 Snapin slightly suppressed the VDI in hyperpolarized voltage 
A. Snapin suppressed the VDI of CaV1.342 in -40 mV, but not the peak current at -10 
mV. B. Snapin did not significantly affect VDI of CaV1.342∆E11 
 









-40 mV 0.776 ± 0.024 0.853 ± 0.024# 0.807 ± 0.035 0.883 ± 0.032 
-30 mV 0.817 ± 0.022 0.873 ± 0.026 0.879 ± 0.034 0.847 ± 0.039 
-20 mV 0.851 ± 0.029 0.844 ± 0.022 0.900 ± 0.021 0.857 ± 0.022 
-10 mV 0.814 ± 0.035 0.764 ± 0.027 0.854 ± 0.018 0.815 ± 0.023 
0 mV 0.741 ± 0.042 0.699 ± 0.025 0.759 ± 0.022 0.755 ± 0.019 
10 mV 0.687 ± 0.038 0.642 ± 0.027 0.677 ± 0.028 0.697 ± 0.025 
20 mV 0.653 ± 0.032 0.583 ± 0.039 0.807 ± 0.035 0.568 ± 0.051 
n 15 11 12 24 
#p < 0.05, compared between CaV1.342 vector and  CaV1.342 snapin in -40 mV 
(Student’s t test, two tail, unpaired). 
  















3.3.4 Alternative splicing of CaV1.3 I-II loop in cochlea 
Several splice sites in CaV1.3 I-II loop have been identified, which 
could generate CaV1.3 channel functional diversity. Exon 11 has been 
shown to alternatively splice in the CaV1.3 I-II loop. In addition to exon 
11, exon 9* is also alternatively spliced in the I-II loop.  
Here, we investigated the alternative splicing of the I-II loop in adult rat 
cochlea. The splicing pattern of CaV1.3 I-II loop was determined by RT-
PCR and colony screening (Tang et al 2004, Liao et al 2007). We 
extracted the cochlear RNA from five 8-9 weeks old rats and obtained 
the cDNAs using specific reverse primer at exon 17 of CaV1.3 for the 
first strand reverse transcription reaction. The sequential PCRs were 
performed to amplify the amplicons spanning exons 9-14. Multiple 
bands were shown in 2% agarose gel (Fig. 3.6B), suggesting that exon 
9* or exon 11 were alternatively spliced in the I-II loop of CaV1.3 
channels found in the cochlea.  
To quantify the inclusion ratio of the alternative exons, we cloned the 
PCR amplicons into TA vector and transformed them into E.coli. 
Multiple E.coli colonies were then picked and colony PCR performed 
and individual clones were screened in 2% agarose gels. Because the 
exon 9* (84 bp) is 24-nt longer than exon 11 (60 bp), we were able to 
identify the presence or absence of an alternative exon by PCR 
product size. The ∆E9*/E11 amplicons was 24 bp shorter than 
E9*/∆E11 and the ∆E9/∆E11 amplicons were the smallest PCR 




determined by the PCR product sizes and the ratio. The sequences of 
randomly selected PCR amplicons were confirmed by direct DNA 
sequencing (Fig. 3.7B). Our results show that the expression level of 
exon 11 was 34% and that of exon 9* was 24%. Compared to the 
previous studies performed in immature rat cochlea, exon 11 
expressions was higher in adult than in young rat pups. Exon 9* was 
much less expressed in adult cochlea than that in young rats. As a 
summary, the alternative splicing pattern of CaV1.3 is under 
developmental regulation in young and adult rat. The temporal 
regulation of CaV1.3 alternative splicing may contribute to the 




                  
Figure 3.6 Multiple splice variants found in CaV1.3 I-II loop of adult rat cochlea. 
A. Possible combinations of CaV1.3 I-II loop splicing pattern of exon 9* and exon 11. 
B. Agarose gel detected multiple bands (550-700 bp) of PCR products amplified from 
cochlear RNA, indicating several splice variants of CaV1.3 I-II loop. PCR products of 
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Figure 3.7 Splicing patterns of CaV1.3 I-II loop. 
A. Colony PCR screening of amplicons from mRNA isolated from rat cochlea shows 
the existence of multiple variants with alternative splicing of exon 9* and exon 11. 
The expected sizes of ∆E9*/∆E11 (573 bp), ∆E9*/E11 (633 bp) and E9*/∆E11 (657 
bp) are shown. B. The random colonies were sequenced to confirm the splicing 
pattern. The DNA sequencing results of the transcripts of alternative spliced exon 9* 
and exon 11 are shown. C. Summary bar chart showed the expression levels of exon 
9* (24%) and exon 11 (34%) in adult rat cochlea. The percentages of exon 9* and 
exon 11 are shown in grey. The numbers in parentheses above each bar indicate the 
number of colonies screened. D. Western blot results using anti-CaV1.3 antibody 
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In this study, we have identified the interaction between snapin and 
exon 11 of CaV1.3 and snapin increased the current density of CaV1.3. 
However, snapin did not affect voltage sensing of the channels. Exon 
11 is an alternative exon and our result showed that 34% of the exon 
11 is included in the CaV1.3 transcripts in cochlea. In addition to 
CaV1.3, snapin had no effect on other neuronal VGCCs from the CaV1 
family, such as CaV1.2 and CaV1.4.  
3.4.1 Spatial and temporal regulation of CaV1.3 I-II loop 
alternative splicing  
The onset of hearing is about 2 weeks after birth for most rodents 
(Fuchs 2005, Safieddine et al 2012). During the period before hearing 
onset, Ca2+ influx from CaV1.3 mediated spontaneous action potentials. 
This process supports tonic synaptic activity and maturation of the 
auditory system. It has been shown that CaV1.3 in immature IHCs 
showed increased Ca2+ current density and stronger voltage-
dependent inactivation as compared to that observed in the mature hair 
cells (Inagaki & Lee 2013). The coupled Ca2+-activated K+ channels 
induced repolarization of the action potential waveforms. It may be 
required to maintain the proper shape and timing of spontaneous 
action potentials.  
In this study, we have examined the splicing pattern of CaV1.3 I-II loop 




third of CaV1.3 transcripts and exon 9* is found in 24% of the 
transcripts. Unpublished work from our laboratory also examined the I-
II loop splicing pattern of CaV1.3 in young rat of 1-2 weeks old as well 
as heart and brain cDNA libraries. To combine these studies together, 
we found that the alternative splicing at the I-II loop is under spatial and 
temporal regulation. We showed that exon 11 expression in rat cochlea 
increased with age. There was less than 6-14% inclusion of exon 11 in 
immature rats cochlea and our studies showed that exon 11 expression 
was much higher at 34% in adult rat cochlea. Exon 11 expressions in 
total brain and heart (30% inclusion) are comparable with that found in 
cochlea. On the contrary, exon 9* expression in cochlea decreased 
during development. It decreased from more than 60% at two-week-old 
rats to 23% in the adult. Exon 9* of CaV1.3 is expressed at a relatively 
low level in heart (5.4%) and brain (2.7%). The changing expression of 
exon 9* and exon 11 of CaV1.3 channels in cochlea may contribute to 
the development and function of the auditory system.  
3.4.2 Snapin interacted with CaV1.3  
Activation of CaV1.3 channels followed by Ca2+ influx triggers vesicle 
release in the ribbon synapse. In immature inner hair cells, CaV1.3 has 
a lower activation threshold and conducts larger currents compared to 
CaV1.3 in adult IHCs. When snapin interacts with CaV1.3 the net result 
would be an increase in current density and a shift of the activation 
threshold to lower potential. Therefore, in the presence of snapin, 




potentials. The snapin-CaV1.3 binding may therefore likely shape the 
channel in the immature pattern. In adult IHCs, snapin binding may 
lead to more Ca2+ influx. It would therefore facilitate neurotransmitter 
release. Snapin has been identified as a synaptic protein and known to 
promote the interaction between Ca2+ senor, Syt-I and vesicle fusion 
machinery protein, SNAP-25 (Ilardi et al 1999, Tian et al 2005, Pan et 
al 2009). Snapin may recruit calcium channels to the active zones in 
the ribbon synapse it has been shown that CaV1.3 channels were 
loosely attached in the active zone. In immature IHCs, most of the 
CaV1.3 channels are present outside the presynaptic region and they 
mediated the firing of spontaneous action potentials instead of 
triggering vesicle release (Zampini et al 2010). It is not clear what may 
the underlying mechanisms be for trafficking CaV1.3 to the ribbon 
synapse. Since snapin has been shown to be involved in trafficking of 
several membrane proteins, snapin-CaV1.3 interaction might be a 
possible mechanism in locating CaV1.3 to the pre-synapse. 
CaV1.3 functions have dual roles in immature and mature IHCs. It has 
not been shown whether snapin in the cochlea is regulated in different 
developmental stages. However, our findings on the alternative splicing 
of exon 11 suggested that alternative splicing of exon 11, which is 
modulated in development, might modulate the snapin-CaV1.3 
interaction. If exon 11 is excluded from the transcripts, snapin could not 
bind to CaV1.3. Therefore, the alternative splicing of exon 11 may be a 




3.4.3 Essential role of CaV1.3 I-II loop in channel properties 
The I-II loop is critical for interacting with the auxiliary β-subunit by the 
AID domain in exon 9. In CaV1.2, exon 9 binds to galectin-1 and 
compete for the binding of β subunit, which could lead to decreased 
surface expression of channel. Alternative inclusion of exon 9* disrupt 
the interaction between galectin-1 and CaV1.2 (Wang et al 2011). 
Similar to exon 9*, exon 11 also extended the I-II loop. We would like to 
determine whether the inclusion of exon 11 or snapin interaction in the 
I-II loop might also affect I-II loop structure in future studies. 
Alternative splicing of exons in the I-II loop of CaV1.3 has been 
examined in rat cochlea and chick basilar papilla (Xu & Lipscombe 
2001). Our study has revealed that inclusion of exon 11 is crucial for 
snapin binding to CaV1.3. We found that snapin slightly suppressed 
VDI in hyperpolarized voltage. The snapin-binding to I-II loop may 
obstruct the closure of I-II loop “hinge”. This effect was not found in 
CaV1.3∆E11. It has been reported that several amino acids in S6 
segment repel the “hinge” closure and suppress the VDI (Tadross et al 
2010). Therefore, exon 11 and I-S6 of CaV1.3 may modulate VDI 
together.  
3.4.4 Conclusion and future studies 
In this study, we have examined the interaction between snapin and 
neuronal CaV1 channels. Snapin preferentially increased the current 
density of CaV1.3 but not on CaV1.2 and CaV1.4. In addition, snapin 




crucial for snapin-CaV1.3 interaction and CaV1.3∆E11 did not bind to 
snapin as shown in GST pull down assay and Co-immunoprecipitation. 
The inclusion ratio of spliced exon 11 in CaV1.3 appears higher in adult 
rat cochlea than immature ones. Therefore, snapin-CaV1.3 interaction 
and alternative splicing of CaV1.3 I-II loop may contributes the 
functional diversity of CaV1.3 in cochlea in different developmental 
stages. 
Further studies would be performed to examine how snapin affects the 
CaV1.3 in cochlea development. We would first compare the snapin 
expression in immature and adult cochlea by real time PCR. Then, we 
would like to knock down snapin expression in cochlea using shRNA 
and examine whether the cochlea development are altered.   
In collaboration with Dr. Tan from University of Melbourne, we aim to 
examine the expression of snapin and CaV1.3 in the cochlear whether 
the snapin and CaV1.3 is co-localized in the inner hair cell and out hair 
cell. This study may provide some evidence on the role of snapin-
CaV1.3 interactions in hearing formation or auditory system 
developments. 
In addition, CaV1.3 is reported to be under extensively alternative 
splicing. The long form and short form of CaV1.3 determined by 42/42a 
splicing are distinct in current density and calcium dependent 
inactivation. The distal C-terminals also affect the CaM binding (Liu et 
al 2010). Since we have examine the effects of snapin on long form of 




the short form (CaV1.342a) with or without exon 11 using electro-













4.1.1 Ganglioside structure and function 
Gangliosides are widely expressed on cell membrane and are involved 
in processes such as cell-cell recognition, cell migration and vesicle 
releases. Gangliosides are composed of three components: lipophilic 
fatty acid, sphingosine base and hydrophilic carbohydrate chain. The 
carbohydrate portion of ganglioside usually contains one or more 
sialosyl groups that are synthesized by specific glycosyltransferases 
(GTs). Various subtypes of gangliosides have been identified based on 
their carbohydrate chains, such as GM GD, GT and GQ, where M, D, T 
and Q represent mono-, di-, tri-, and quadri-sialosyl groups (Fig 4.1A) 
(Irie et al 1994). 
Gangliosides are abundant in the nervous system. In the plasma 
membrane, gangliosides and cholesterol are segregated into 
membrane micro-domains known as lipid rafts. It is one of the critical 
regions in signal transduction and protein trafficking. Concentration of 
various proteins in these rafts facilitates protein-protein interactions and 
the microenvironment of lipid rafts may therefore alter the protein 
conformation and function (Anderson & Jacobson 2002, Ohmi et al 
2012). For example, the potassium channel KV2.1 targets to the lipid 
raft. The peak current and voltage sensing of the KV2.1 were altered 
when cholesterol was depleted and the lipid raft formation was 





Figure 4.1 Structure of gangliosides including GM1, GD1a and GQ1b. 
A. Ganglioside is composed by ceramide and oligosaccharide with one or more sialic 
acids. The ceramides are linked with sphingosine and a fatty acid, which is a crucial 
component for cell membranes. The oligosaccharide groups of ganglioside extended 
beyond the cell surface and could be recognized as surface markers. B. The three 
common gangliosides GM1, GD1a and GQ1b were found to related to GBS. The 





4.1.2 Anti-ganglioside antibody and Guillain-Barré syndrome 
Studies have shown that gangliosides were involved in human 
diseases. Autoantibodies against gangliosides are the major causes of 
Guillain-Barré syndrome (GBS). GBS is characterized by patients 
suffering from acute areflexic paralysis that is associated with high 
protein level in the cerebrospinal fluid. The major symptoms of Guillain-
Barré syndrome are progressive limb numbness and paresthesia. 
Patients usually suffer from hyporeflexia or areflexia as well. It was first 
described by Guillain, Barré and Strohl in 1916 (Guillain et al 1916, 
Koga et al 2012, Yuki & Hartung 2012). Guillain-Barré syndrome is now 
one of the major causes to paralysis with incidence of 1.1 per 100,000 
person per years (Sejvar et al 2011). Elevated protein levels could be 
detected in cerebrospinal fluids obtained by lumbar puncture of 
patients (Nishimoto et al 2004). It was shown that 30% of GBS patients 
have a history of infection by Campylobacter jejuni (Orlikowski et al 
2011). Several other infectious agents including Mycoplasma 
pneumonia, Varicella–Zoster virus and Barr virus have also been 
identified. It is believed that some antigens of the bacteria or virus 
share similar structures to ganglioside and induce an abnormal 
immune response (Jacobs et al 1998, Hadden et al 2001). The current 
popular treatment for GBS is intravenous immunoglublin injection. The 
immune globin may neutralize the autoantibodies against gangliosides 





Guillain-Barré syndrome can be classified as acute inflammatory 
demyelinating polyneuropathy (AIDP) and acute motor and axonal 
neuropathy (AMAN) based on the underlying pathologies (Hadden et al 
1998, Hiraga et al 2003). The classical pathologies in AIDP are 
progressive demyelination with inflammatory infiltrates. The 
demyelinating axons are covered with microphages and subsequently 
they will result in axonal degeneration. In AMAN pathologies, IgG binds 
to the nodes of Ranvier of motor fibers and the following immune 
responses lead to detachment of membrane proteins in the nodes of 
Ranvier (McKhann et al 1993). The demyelinating form of GBS, AIDP, 
is prevalent in Europe and North America, whereas, the axonal form, 
AMAN, accounts for more than 60% of the GBS in Asia (Hadden et al 
1998, Islam et al 2010). Miller Fisher syndrome (MFS) appears to be a 
unique variant of GBS that is characterized by paralysis of the eye 
muscles and ataxia. This suggests that the underlying pathologies are 
in the central nervous system. It is commonly found among patients in 
China and Japan (Fisher 1956, Willison 2005).  
Both the AMAN and MFS are highly associated with autoantibodies 
against gangliosides. In AMAN patients, antibodies against GM1 and 
GD1a are found in the spinal fluids (Capasso et al 2003, Sekiguchi et 
al 2012). As GM1 and GD1a are highly expressed in the motor and 
sensory neurons, this could explain preferential motor axon injury in 
AMAN patients (Lopez et al 2010, Capasso et al 2011). Anti-GM1 or 
anti-GD1a, two antibodies associated with AMAN could suppress 




hypothesized that both patient serum and IgG-GD1a could inhibit 
acetylcholine evoked synaptic release in rat muscle-spinal cord co-
culture (Taguchi et al 2004). As Ca2+ influx through VGCCs is crucial to 
initiate neurotransmitter release, VGCCs have been shown to be 
involved in the pathology of GBS. Rabbit GD1a-positive sera reversibly 
inhibit the VGCC currents in PC12 pheochromocytoma cells (Nakatani 
et al 2007). In addition to anti-GD1a, anti-GM1 has been shown to 
inhibit quanta release and Ca2+ influx into the presynaptic site of the 
neuromuscular junction (Buchwald et al 2007).  
On the contrary, antibodies to GQ1b, which can cross-react with GT1a, 
are associated with MFS. GQ1b is strongly expressed in ocular motor 
muscles and limb muscles (Chiba et al 1993, Nagashima et al 2007). 
Nakatani et al (2009) has found that both AMAN patient serum and 
anti-GM1 antibody could reversibly inhibit the CaV2.1 channels 
expressed in the Purkinje cells of the cerebellum, while anti-GQ1b only 
inhibited Ca2+ currents in granule cells but not in Purkinje cells. These 
results suggest that altered VGCC function by anti-ganglioside 
antibody might contribute to ataxia in GBS patients (Nakatani et al 
2009a, Nakatani et al 2009b). 
4.1.3 Interaction between lipid raft and calcium channel 
The Ca2+ influx through VGCC triggers a few intracellular events. It is 
thought that VGCCs are clustered within the lipid raft to facilitate the 
signal transduction process. Davies et al. (2006) has revealed the 




on the auxiliary α2δ subunits. The α2δ subunits are linked by disulfide 
bonds between the α2- and δ-subunit, Four variants of the α2δ subunit 
have been identified in human, namely α2δ-1, α2δ-2 α2δ-3 and α2δ-4. It 
has been shown that α2δ-2 and CaV2.1 are enriched in the lipid-raft 
region in mouse cerebellum and tsA-201 cells. The calcium channel 
current is reduced when the α2δ subunit is excluded in the 
heterologous expression of VGCCs in cell lines. Furthermore, 
cholesterol depletion could disrupt lipid raft formation leading to 
attenuation of the enhancing effects of α2δ on calcium channel currents 
(Davies et al 2006). Similar studies by Robinson et al (2010) indicated 
that CaV2.2 were also clustered with lipid raft and co-localization of 
CaV2.2 and lipid raft marker caveolin required the α2δ-1 subunit. The 
α2δ subunits increase the expression level of various CaV channels to 
affect the physiological function of CaV channels (Hoppa et al 2012). 
The mature α2δ subunit can be extensively glycosylated and about 9-
12 glycosylation sites from 15 predicted sites can be utilized (Robinson 
et al 2011). However, how the α2δ subunits interact with the lipid raft is 
not well understood. 
4.1.4 Objectives and rationale 
The current study revealed that various anti-ganglioside antibodies and 
VGCC are both expressed at the neuromuscular junction and 
cerebellum, which may be related to the pathology of the GBS. 
However, the mechanism of the interaction between calcium channels 




shown that several kinds of anti-ganglioside antibodies have been 
detected in GBS and MFS patient serum. What or which group of anti-
gangliosides will be the major component in the pathological process? 
Secondly, given that VGCC is a hetero-oligomeric complex with a main 
pore-forming subunit and several auxiliary units, it is not clear which 
subunit(s) of VGCC is pivotal in interacting with gangliosides or anti-
ganglioside antibody. Here, we are interested to investigate whether 
the main pore-forming unit or the auxiliary subunits interact with 
antibodies to gangliosides.  
 
 
Figure 4.2 The proposed interaction between ganglioside and voltage-gated calcium 
channel, including α1, β and α2δ. 
The anti-ganglioside antibodies may recognize the gangliosides in the cell membrane. 
The α2δ subunit is highly glycosylated. There might be potential interaction between 





4.2 Materials and methods 
4.2.1 Sera samples 
Sera from MFS patients presenting to University Malaya Medical 
Centre (Kuala Lumpur, Malaysia) and Dokkyo Medical University 
(Tochigi, Japan) were collected. Informed written consent was obtained 
from each patient. Normal human sera were prepared from five healthy 
subjects as a complement source.  
4.2.2 Monoclonal anti-ganglioside antibodies 
Mouse IgG mono-clone anti-GM1, anti-GD1a and anti-GQ1b antibodies 
were prepared by Dr. Yuki (Department of Medicine, NUS). It was 
stored in 4°C until use.  
4.2.3 Cell culture and treatments 
HEK293 cell were maintained DMEM with 10% FBS and grown in 37°C 
incubator with 5% CO2. 1% Pen/strip were added to avoid 
contamination.  
CaV2.1 and auxiliary subunits was transiently transfect by calcium 
phosphate methods. The α1 pore-forming units (1.7 μg), β2a (1.25 μg) 
and α2δ1 (1.25 μg) DNA plasmid as well as T-antigen (0.25 μg) were 
mixed with 75 μl of CaCl2 and 75 μl of 2XHBS buffer. The mixture was 
incubated in room temperature for 15-20 minutes and gently added into 
culture dishes. After 3-5 hours, fresh media without antibiotic were 




gangliosides (5 μg/ml) or patient serum (1:200) were added 24 hours 
before electrophysiological experiments. 
4.2.4 Whole cell patch clamp electrophysiology 
Whole cell patch-clamp recording on HEK293 cell channel were 
performed within 36-72 hours after transfection as previously reported. 
The external solution contained (in mM) 10 HEPES, 140 TEA-MeSO3 
and 5 BaCl2 (pH 7.4, Osmolarity 300-310 mOsm). The glass pipette 
solution was backfilled with pipette solution (in mM) 10 HEPES, 5 CsCl, 
138 Cs-MeSO3, 0.5 EGTA, 1 MgCl2, 2 mg/ml MgATP (pH 7.3 
Osmolarity 290-300 mOsm).  
HEK cells were held at -90 mV by voltage clamp using Axopatch 700B. 
The series resistance for recording was typically less than 5 MΩ, 70-
80% compensation on serial resistance and cell membrane 
capacitance was applied. A P/4 protocol was applied to subtract the 
leakage current. All data were obtained with Digidata 1440A, sampled 
at 5-50 kHz. The 1 kHz or 6 kHz low pass filter are applied for all the 
data. 
In order to study the activation threshold of voltage-gated calcium 
channel, we performed the studies using tail protocol, which represent 
the conductivity of channel. Cells were depolarized to a serials of 
voltages, ranging from -60 to 100 mV, in steps of 10 mV increments, 





4.2.5 Data analysis 
The electrophysiology data were analyzed and plotted by using Prism 6 
software (San Diego, CA), and were displayed as mean values ± SEM. 
Statistical significance of differences between two groups were 
analyzed with unpaired, two-tail Student’s t-test. 
In order to analyze the V1/2act, which represent the voltage thresholds 
for activating the VGCC. The tail current was normalized to the 
maximum current obtained from each cell and fitted through single 
Boltzmann equation: 
ܩ	 ൌ 	ܩ௠௜௡ ൅	ሺܩ௠௔௫ 	െ	ܩ௠௜௡ሻ ሺ1 ൅ ݁
௏భ/మೌ೎೟	ି	௏
௞ೌ೎೟ ሻ⁄  
where G represent the tail current, V is the membrane potential of the 
test pulse. The following parameters were determined by curve fitting. 
Gmax is the maximum tail current recorded from each cell, Gmin is the 
maximum tail current recorded for fitting curve. kact is the slope factor 
and V1/2act represents the voltage when the channel current reaches 
half of the maximum current. 
The I-V curve and V1/2inact, were analyzed as previously described in 






4.3.1 Antibody of GM1 interacts with calcium channel. 
Three major autoantibodies against ganglioside were found to be 
associated with the GBS. To investigate the relationships between anti-
ganglioside, Dr. Yuki (Department of Medicine, NUS) has generated 
antibodies and the mono-clone antibodies against the ganglioside. The 
specificity of antibodies was shown in the previous studies and the anti-
GM1, anti-GQ1b and anti-GD1a did not cross-react with other epitopes 
(Lopez et al 2010, Nakatani et al 2007, Nishimoto et al 2004). In order 
to investigate the interactions between anti-ganglioside antibodies and 
CaV2.1, we used whole-cell patch clamp electrophysiology to examine 
calcium channel properties. We transfected the HEK293 cell with 
CaV2.1 and incubated anti-ganglioside antibodies (5 μg/ml) with the 
HEK cell for 24 hours before electrophysiology experiments.  
We first examined the activation voltage CaV2.1 by both current-voltage 
(I-V) curve and Tail protocol. For I-V curve, a family of depolarization 
steps was delivered to activate the voltage-gated calcium channel. 
Further studies using tail protocol exhibited the effect of anti-GM1 on 
activation curve. The tail protocol was generated by a family of 20 ms 
test pulse (-60 mV to 100 mV) and -50 mV repolarization followed by 
each step. In figure 4.3, we found that the anti-GM1 antibodies shifted 
the activation voltage of CaV2.1 channels to hyperpolarized voltage by 
about 4 mV as represented by V1/2act. (V1/2act IgG, -5.33 ± 1.26 mV, n = 




Moreover, we compared the inactivation curve by steady-state 
inactivation. Our results showed that the anti-GM1 has no effect on 
steady-state inactivation of CaV2.1 (V1/2inact IgG, -28.75 ± 1.01 mV, n = 
11; V1/2inact anti-GM1, -27.01 ± 0.85 mV, n = 7). Therefore, the opening 
threshold of CaV2.1 was reduced with the presence of anti-GM1. The 
anti-GM1 did not affect the current density of CaV2.1 (IgG, 228.8 ± 
6.46, n = 25; anti-GM1, 238.2 ± 8.52, n = 19). These results suggested 
that the anti-GM1 affected the voltage sensing of CaV2.1 calcium 
channels.  
Table 4.1 Electrophysiological properties of the CaV2.1 incubated with anti-GM1. 










-5.33 ± 1.26 
(10) 
-4.48 ± 1.58 
(10) 
-9.57 ± 0.93 
(7) 
-0.37 ± 0.88* 
(9) 
Imax Tail  
(pA/pF) 
215.2 ± 5.2 
(25) 
205.7 ± 4.9 
(15) 
227.6 ± 5.6 
(19) 
227.3 ± 6.6 
(18) 
The number of experiments is indicated in parentheses. V1/2act represent potential of 
half activation, which V1/2act was derived from tail-activation curves recorder in Ba2+ 
solution (Fig. 4.4). For statistics, *p < 0.001, compared with same group with or 







Figure 4.3 Anti-GM1 antibody shifted the activation threshold to hyper-polarized 
voltage. 
A. Normalized I-V curve properties of CaV2.1 with Anti-GM1 (red) and IgG (black). 
Anti-GM1 antibody shifted I-V curve of CaV2.1 to left by 4 mV. Upper panel, 
exemplary trace of Anti-GM1 (red) and IgG (black) were shown. Calibration bar, 500 
ms, 1 nA.  B. Normalized activation curve with Anti-GM1 (red) and IgG (black) 
recorded by tail protocol.  Anti-GM1 antibody shifted the activation curve to CaV2.1 to 
left. Upper panel, Exemplary trace of Anti-GM1 (red) and IgG (black) were shown. 
Calibration bar, 20 ms, 1 nA.   C. The current density of CaV2.1 with Anti-GM1 (red) 
and IgG (black) recorded in Tail protocol.  Anti-GM1 antibody did not affect the 
current density of CaV2.1. D. Anti-GM1 antibody did not affect steady-state 
inactivation. Upper panel, Exemplary trace of Anti-GM1 (red) and IgG (black) were 
shown. Calibration bar, 50 ms, 1 nA.    
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4.3.2 α2δ subunit was involved in the interaction between anti-
GM1 antibodies and CaV2.1 
The calcium channel is formed as a hetero-oligomeric complex, which 
is composed of the α1-, β- and α2δ-subunit, in which the α2δ-subunit is 
highly glycosylated and attached to the extracellular leaflet of cell 
membrane (Fig. 4.2). We investigated whether α2δ-subunit is involved 
in the interaction between anti-GM1 and CaV2.1. In this study, we 
excluded the α2δ-subunit in the heterogeneous expression system in 
HEK cell and the CaV2.1 was still functional (Fig. 4.4A). The V1/2act of 
IgG group without α2δ (-4.48 ± 1.58 mV, n = 10) had no significant 
difference to that with α2δ (-5.33 ± 1.26 mV, n = 10). The current 
density CaV2.1 with α2δ subunit is slightly bigger than that without α2δ 
subunit (Table 4.1). However, The V1/2act of anti-GM1 without α2δ (-9.57 
± 0.93 mV, n =7) is significant lower than that with α2δ subunit (-0.37 ± 
0.88 mV, n = 9; p < 0.001), as shown in figure 4.4, suggesting that 
without the presence of α2δ subunit, the anti-GM1 antibody did not shift 
the opening threshold to hyperpolarized voltage. These studies 
indicated that α2δ subunit is involved in the interaction between anti-







Figure 4.4 α2δ subunit abolished the interaction between anti-GM1 and CaV2.1  
A. The activation curves of CaV2.1 with α2δ subunit (filled) and without α2δ subunit 
(open) were shown with IgG incubation. α2δ subunit did not affect the activation 
voltage threshold of CaV2.1. Upper panel, Exemplar current traces of IgG w/ α2δ, IgG 
w/o α2δ. B. Anti-GM1 antibody only shifted the activation to left when α2δ subunit was 
present. The activation potentials of CaV2.1 with α2δ subunit (filled) and without α2δ 
subunit (open) are shown with incubation of anti-GM1. Upper panel, example traces 
of anti-GM1 w/ α2δ and anti-GM1 w/o α2δ. Calibration bar. 20 ms, 1nA. C. Summary 
chart showed the detail of V1/2act of CaV2.1 with or without of α2δ subunit or incubation 
with IgG or anti-GM1 antibodies. D. The current densities of CaV2.1 with α2δ subunit 
(filled) and without α2δ subunit (open) are shown with incubation of IgG. E. The 
activation curves of CaV2.1 with α2δ subunit (filled) and without α2δ subunit (open) are 





4.3.3 Anti-GD1a and anti-GQ1b modulated the calcium channel 
properties 
In comparison with anti-GM1 antibodies, we have also evaluated the 
function of anti-GD1a and anti-GQ1b antibodies on CaV2.1 channels. 
Anti-GD1a is usually found in patient sera of AMAN subtype of GBS 
along with anti-GM1 antibodies. Both of them affect the transmitter 
release in neuromuscular junction (NMJ) (Nakatani et al 2007). Our 
results showed that the anti-GD1a antibodies only decreased the 
current density (anti-GD1a, 130.8 ± 6.63, n = 8; p < 0.001; Figure 4.5B) 
without affecting the activation potentials (anti-GD1a, -2.90 ± 0.69, n = 
8; Figure 4.5A). 
 
Figure 4.5 Anti-GD1a antibody decreased the current density of CaV2.1 
A. Normalized activation curve with Anti-GD1a (blue) and IgG (black) recorded by tail 
protocol.  Anti-GD1a did not affect V1/2act of the CaV2.1 Upper panel, exemplary trace 
of Anti-GD1a (blue) Calibration bar, 20 ms, 1 nA.   B. The current density of CaV2.1 
with Anti-GD1a (blue) and IgG (black, dash) recorded in Tail protocol. Anti-GD1a 
antibody decreased the current density of CaV2.1.  
 































The anti-GQ1b antibodies were found at the MFS patient sera and it 
was reported that anti-GQ1b affected the neuron functions in central 
nervous systems (Nakatani et al 2009b). In our studies, contrary to the 
effects of anti-GM1 antibodies, the anti-GQ1b antibodies shifted the 
activation curve of CaV2.1 to the hypo-polarized direction (IgG, -5.03 ± 
1.06, n = 14; anti-GQ1b, -0.59 ± 0.53, n = 9; p < 0.001; Figure 4.6A). 
The patient sera from MFS exhibited similar effect on CaV2.1 (IgG, -
13.55 ± 1.02, n = 8; anti-GQ1b, -3.61 ± 0.83, n = 8; p < 0.001; Figure 
4.6B). However, the anti-GQ1b antibody did not affect CaV2.1 channel 
current density (IgG, 230.9 ± 7.07, n = 14; anti-GQ1b, 204.4 ± 9.36, n = 
9; Figure 4.6C). These results revealed the diversified function of 
different anti-ganglioside antibodies on the CaV2.1 calcium channel 
function. 
 
Table 4.2 Electrophysiological properties of the CaV2.1 incubated with anti-GD1a or 
anti-GQ1b 
 IgG anti-GD1a anti-GQ1b 
V1/2act 
(mV) 
-5.33 ± 1.26 
(10) 
-2.90 ± 0.69 
(9) 




215.2 ± 5.2 
(25) 
130.8 ± 6.6* 
(9) 
204.4 ± 3.3 
(8) 
The number of experiments is indicated in parentheses. V1/2act represent potential of 
half activation, which V1/2act was derived from tail-activation curves recorder in Ba2+ 
solution (Fig. 4.5, 4.6). For statistics, *p < 0.001, compared with IgG group  (Student’s 







Figure 4.6 Anti-GQ1b antibody shifted the activation potentials of CaV2.1 to hypo-
polarized voltage. 
A. Normalized activation curve of GQ1b (cyan) and IgG control (black, dash) 
recorded by tail protocol were shown.  Anti-GQ1b shifted the activation potentials of 
CaV2.1 to the right. Upper panel, exemplary trace of Anti-GQ1b (Cyan). Calibration 
bar, 20 ms, 1 nA.   B. Normalized activation curve of MFS patient sera (cyan) and 
IgG control  sera (black, dash) recorded by tail protocol were shown.  MFS patient 
sera shifted the activation curve of CaV2.1 to the right. Upper, Exemplary trace of 
MFS patient sera (cyan). C. The current density of CaV2.1 with Anti-GQ1b (cyan) and 
IgG (black, dash) recorded in Tail protocol.  Anti- GQ1b antibody did not affect the 






















































4.4.1 Antibody of GM1 interacts with calcium channel. 
In this study, we have discovered that antibody against GM1 could 
modulate the voltage sensing of CaV2.1 channels and shift the 
activation potentials of the channels to the hyperpolarized direction. In 
this way, the calcium channels may open with a relatively lower voltage 
threshold with anti-GM1 antibodies than that under normal conditions. 
The inactivation curve of CaV2.1 was however not changed. Therefore, 
the channel has relatively large window currents when activated in the 
presence of anti-GM1 antibodies. Anti-GM1 is found in AMAN patient 
sera. Studies have shown that anti-GM1 depressed calcium influx and 
evoked quantal release in NMJ (Buchwald et al 2007). The opening 
threshold of CaV2.1 was lower with anti-GM1 than normal conditions. It 
may lead to excessive calcium influx in NMJ and consequently 
paralysis on the muscle. Therefore the effect of anti-GM1 on CaV2.1 
voltage sensing might provide one of the potential mechanisms 
contributing to the muscle weakness in axonal form of GBS. 
4.4.2 α2δ subunit is involved in the interaction between anti-GM1 
antibodies and CaV2.1 
In our studies, we found that the α2δ-subunit of the CaV2.1 calcium 
channel was involved in the interaction between anti-GM1 antibody and 
CaV2.1. The α2δ subunits integrate the calcium channel into the lipid 
raft. Davies et al has shown that α2δ-2 and CaV2.2 are enriched in the 




of CaV2.2 and lipid raft marker caveolin requires α2δ-1 subunit 
(Peterson et al 2000, Davies et al 2006). The direct interaction between 
gangliosides and α2δ subunit of VGCC has not been shown before. 
Given that the ganglioside and cholesterol are major components in the 
rafts, our results suggested that α2δ function might be modulated by 
the gangliosides around the lipid raft regions. It has been shown that 
the mature α2δ subunit can be extensively glycosylated and as such it 
is possible that these glycosylation sites are important to mediate the 
interaction between CaV2.1 channels and anti-ganglioside antibody 
(Fig. 4.2). It is not clear yet on the details of the molecular interaction 
between CaV2.1 channel and anti-GM1 antibody, but we propose two 
possible hypotheses. One, the anti-ganglioside antibodies could 
directly bind to the α2δ calcium channel and modulate the calcium 
channel function, or two, the anti-GM1 antibodies could disrupt the 
interaction between Cav2.1 channels and GM1 and therefore the 
calcium channel function is altered. Further studies are necessary to 
elucidate the mechanisms of GM1 and α2δ subunit interactions. 
4.4.3 Different anti-ganglioside antibodies affect the CaV2.1 in 
diversified ways 
The GBS could be categorized into demyelinating (AIDP) and axonal 
subtypes (AMAN), which is associated with various autoantibodies 
against gangliosides (Yuki & Hartung 2012). Anti-GM1 and GD1a 
antibodies are found in AMAN patient’s sera (Lopez et al 2010), but 




ataxia and association with anti-GQ1b antibodies (Chiba et al 1993, 
Fisher 1956). In this study, we have examined the effects of anti-GM1, 
anti-GD1a and anti-GQ1b antibodies on the CaV2.1 voltage-gated 
calcium channels. The results revealed the diversified effects of anti-
ganglioside antibodies on the calcium channel. Anti-GM1 antibodies 
shifted the opening threshold to hyperpolarize potential. Anti-GD1a 
antibodies did not affect the voltage sensing but decrease the calcium 
channel current. Previous studies using AMAN patient’s sera may 
reflect the combined effects of anti-GM1 and anti-GD1a antibodies 
(Nakatani et al 2009a). However, our studies suggested that these two 
auto-antibodies utilized different mechanisms to modulate calcium 
channel function in contributing to AMAN pathologies. As GM1 and 
GD1a are highly enriched in the motor and sensory neurons, the 
diversified effects of anti-GM1 and anti-GD1a may contribute to the 
degeneration of the motor neurons and neuromuscular junctions.  
Anti-GQ1b is associated with MFS. Patients of MFS not only suffer 
from the limb weakness but also ataxia (Mori et al 1999). It is shown 
that GQ1b could be found in the cerebellum and is preferentially 
expressed in the granule cell (Kotani et al 1995, Nakatani et al 2009b). 
It is reported that CaV2.1 mutation cause ataxia (Pietrobon 2010). It is 
possible that the altered calcium channel function may contribute to 
ataxia in Miller-Fisher syndrome.  
The shifting of the activation voltage will affect the open window current 




system. Anti-GM1 shifted the activation curve to left and anti-GQ1b 
shifted the activation curve to right. The voltage sensing of VGCC has 
been reported to affect the calcium channelopathies. CaV2.1 mutation 
V714A and I1815L was associated with FHM1. It is reported that 
V714A and I1815L shifted the voltage range of activation toward more 
negative voltage and lead to increase Ca2+ influx upon action potential. 
In this case, the increased vesicle release may increase the neuronal 
network excitability (Hans et al 1999, Tottene et al 2002). Similarly, the 
anti-GM1 may induce more Ca2+ influx in NMJ and cause muscle 
paralysis while the anti-GQ1b may lead to less Ca2+ influx in central 
nervous system and contribute to ataxia.  
4.4.4 Conclusion and future studies 
The study here presented the functional interaction of anti-ganglioside 
antibodies to CaV2.1. Anti-GM1 and anti-GD1a are found in AMAN 
patient sera. Our results showed that anti-GM1 shift the activation 
curve to hyperpolarized voltage and anti-GD1a decreased the CaV2.1 
channel current. Moreover, the interaction between anti-GM1 and 
CaV2.1 was dependent on the auxiliary α2δ subunit of calcium channel. 
The voltage sensing of CaV2.1 is not affected by anti-GM1 when α2δ 
subunit was removed in the heterologous expression system. On the 
other hand, anti-GQ1a is associated with the in Miller-Fisher syndrome. 
The anti-GQ1b increased the activation threshold of CaV2.1.  
Several further studies would be performed to elucidate the interaction 




Firstly, we would like to examine the physiological effects of anti-GM1 
on the NMJ. We would like to find out whether the neurotransmitter 
release is altered in NMJ when applying the anti-GM1 antibodies. 
Secondly, α2δ is extensively glycosylated. It is unknown that whether 
the glycosylation of α2δ is related to the interaction between anti-GM1 
and CaV2.1. We would like to deglycosylate α2δ subunit and examine 
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